Enzyme Inhibitors [Pharmacological Action]

Tree Number(s): D004791

MeSH Unique ID: D004791

cladosporin (Supplementary Concept)
cyclopiazonic acid (Supplementary Concept)
geldanamycin (Supplementary Concept)
linsidomine (Supplementary Concept)
polyoxorim (Supplementary Concept)
costunolide (Supplementary Concept)
bis(4-nitrophenyl)phosphate (Supplementary Concept)
pyrazofurin (Supplementary Concept)
7-ketocholesterol (Supplementary Concept)
phosphinothricin (Supplementary Concept)
3,3',4',5-tetrachlorosalicylanilide (Supplementary Concept)
N-(3-pyrene)maleimide (Supplementary Concept)
3-hydroxybenzylhydrazine (Supplementary Concept)
pimagedine (Supplementary Concept)
blasticidin S (Supplementary Concept)
diacetylmonoxime (Supplementary Concept)
dipicolinic acid (Supplementary Concept)
hypericin (Supplementary Concept)
lawsone (Supplementary Concept)
juglone (Supplementary Concept)
thiosemicarbazide (Supplementary Concept)
benserazide, levodopa drug combination (Supplementary Concept)
honokiol (Supplementary Concept)
safingol (Supplementary Concept)
3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one (Supplementary Concept)
acivicin (Supplementary Concept)
metoprine (Supplementary Concept)
acetohydroxamic acid (Supplementary Concept)
baicalein (Supplementary Concept)
4-bromophenacyl bromide (Supplementary Concept)
butyl phosphorotrithioate (Supplementary Concept)
diphenyleneiodonium (Supplementary Concept)
etiron (Supplementary Concept)
fluoranthene (Supplementary Concept)
2-iodosobenzoic acid (Supplementary Concept)
3-mercaptopicolinic acid (Supplementary Concept)
5'-methylthioadenosine (Supplementary Concept)
monodansylcadaverine (Supplementary Concept)
2-nitro-5-thiocyanobenzoic acid (Supplementary Concept)
propargylglycine (Supplementary Concept)
ribavirin-5'-phosphate (Supplementary Concept)
surfactin peptide (Supplementary Concept)
trilostane (Supplementary Concept)
mizoribine (Supplementary Concept)
9-(2-hydroxy-3-nonyl)adenine (Supplementary Concept)
elastatinal (Supplementary Concept)
3-acetylpyridine (Supplementary Concept)
phosphoramidic acid (Supplementary Concept)
conduritol epoxide (Supplementary Concept)
androsta-1,4,6-triene-3,17-dione (Supplementary Concept)
dicyclohexylamine (Supplementary Concept)
nikkomycin (Supplementary Concept)
7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (Supplementary Concept)
Cibacron Blue F 3GA (Supplementary Concept)
gabaculine (Supplementary Concept)
sparfosic acid (Supplementary Concept)
nojirimycin (Supplementary Concept)
sulfoquinovosyl diglyceride (Supplementary Concept)
4-amino-5-hexynoic acid (Supplementary Concept)
cytidylyl adenosine (Supplementary Concept)
daidzin (Supplementary Concept)
protein kinase modulator (Supplementary Concept)
8-((4-chlorophenyl)thio)cyclic-3',5'-AMP (Supplementary Concept)
alrestatin (Supplementary Concept)
methyl diethyldithiocarbamate (Supplementary Concept)
bromopyruvate (Supplementary Concept)
2,4-diaminohypoxanthine (Supplementary Concept)
fenvalerate (Supplementary Concept)
zinc protoporphyrin (Supplementary Concept)
sodium arsenite (Supplementary Concept)
W 7 (Supplementary Concept)
acifluorfen (Supplementary Concept)
N,N-dimethylarginine (Supplementary Concept)
2-tert-butylhydroquinone (Supplementary Concept)
prunasin (Supplementary Concept)
2,5-di-tert-butylhydroquinone (Supplementary Concept)
tele-methylhistamine (Supplementary Concept)
rhein (Supplementary Concept)
ethanolamine O-sulfate (Supplementary Concept)
herbimycin (Supplementary Concept)
succinylacetone (Supplementary Concept)
tetrathiomolybdate (Supplementary Concept)
protein phosphatase inhibitor-1 (Supplementary Concept)
tetra(4-N-methylpyridyl)porphine (Supplementary Concept)
placental ribonuclease inhibitor (Supplementary Concept)
steroid delta-isomerase (Supplementary Concept)
bufalin (Supplementary Concept)
4-hydroxyphenylglycine (Supplementary Concept)
bicozamycin (Supplementary Concept)
5-((methylthio)methyl)-2'-deoxyuridine (Supplementary Concept)
tobacco tar (Supplementary Concept)
protein phosphatase inhibitor-2 (Supplementary Concept)
acyclovir triphosphate (Supplementary Concept)
purpurogallin (Supplementary Concept)
uracil-DNA glycosylase inhibitor protein, B. subtilis bacteriophage (Supplementary Concept)
S-methylisothiopseudouronium (Supplementary Concept)
alpha-fluoromethylhistidine (Supplementary Concept)
dazoxiben (Supplementary Concept)
meciadanol (Supplementary Concept)
oxophenylarsine (Supplementary Concept)
imidazole (Supplementary Concept)
triamcinolone diacetate (Supplementary Concept)
maleic acid (Supplementary Concept)
myxothiazol (Supplementary Concept)
tendamistate (Supplementary Concept)
neplanocin A (Supplementary Concept)
3-chlorocatechol (Supplementary Concept)
urokinase inhibitor (Supplementary Concept)
pyrazole (Supplementary Concept)
sorivudine (Supplementary Concept)
2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid (Supplementary Concept)
6-iodopenicillanic acid (Supplementary Concept)
CB 3717 (Supplementary Concept)
calmidazolium (Supplementary Concept)
perillyl alcohol (Supplementary Concept)
levulinic acid (Supplementary Concept)
neocarzinostatin chromophore (Supplementary Concept)
8-aminoguanosine (Supplementary Concept)
tin protoporphyrin IX (Supplementary Concept)
angiotensin II, Sar(1)-Ile(5)- (Supplementary Concept)
13-hydroperoxylinoleic acid (Supplementary Concept)
RV 538 (Supplementary Concept)
N-methyldeoxynojirimycin (Supplementary Concept)
hexylglutathione (Supplementary Concept)
5,6-dihydroxyindole (Supplementary Concept)
proteinase inhibitor II protein, plant (Supplementary Concept)
5-iodotubercidin (Supplementary Concept)
ozagrel (Supplementary Concept)
digoxin-like factors (Supplementary Concept)
3-deazaaristeromycin (Supplementary Concept)
triacsin C (Supplementary Concept)
5-benzylacyclouridine (Supplementary Concept)
5-propenyl-dUTP (Supplementary Concept)
Sch 28080 (Supplementary Concept)
monorden (Supplementary Concept)
3,4-dihydroxybenzohydroxamic acid (Supplementary Concept)
2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Supplementary Concept)
concanamycin A (Supplementary Concept)
amonafide (Supplementary Concept)
M 79175 (Supplementary Concept)
brodimoprim (Supplementary Concept)
pirmagrel (Supplementary Concept)
castanospermine (Supplementary Concept)
baicalin (Supplementary Concept)
N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide (Supplementary Concept)
epalrestat (Supplementary Concept)
thiazole-4-carboxamide adenine dinucleotide (Supplementary Concept)
2',5-difluoro-2'-deoxy-1-arabinosyluracil (Supplementary Concept)
2',3'-dideoxyguanosine 5'-diphosphate (Supplementary Concept)
dazmegrel (Supplementary Concept)
furegrelate (Supplementary Concept)
SAN 58035 (Supplementary Concept)
fostriecin (Supplementary Concept)
N(2)-(4-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate (Supplementary Concept)
heliodermin (Supplementary Concept)
tolrestat (Supplementary Concept)
isoliquiritigenin (Supplementary Concept)
bafilomycin A1 (Supplementary Concept)
7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester (Supplementary Concept)
doxorubicin-iron complex (Supplementary Concept)
ribosomal protein L34 (Supplementary Concept)
6-anilino-5,8-quinolinedione (Supplementary Concept)
sulfometuron methyl (Supplementary Concept)
ponalrestat (Supplementary Concept)
ticarcillin-clavulanic acid (Supplementary Concept)
N-chlorotaurine (Supplementary Concept)
6-methoxy-2-naphthylacetic acid (Supplementary Concept)
isbogrel (Supplementary Concept)
miglitol (Supplementary Concept)
emeriamine (Supplementary Concept)
cyclopentenyl cytosine (Supplementary Concept)
flurithromycin (Supplementary Concept)
brequinar (Supplementary Concept)
BM 15766 (Supplementary Concept)
R 59022 (Supplementary Concept)
2,2'-thiodiethanol (Supplementary Concept)
erbstatin (Supplementary Concept)
ACTH (4-7), Pro-Gly-Pro- (Supplementary Concept)
5-vinyl-1-arabinofuranosyluracil (Supplementary Concept)
atamestane (Supplementary Concept)
ajoene (Supplementary Concept)
3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid (Supplementary Concept)
Y 20811 (Supplementary Concept)
staurosporine aglycone (Supplementary Concept)
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole (Supplementary Concept)
rebamipide (Supplementary Concept)
tautomycin (Supplementary Concept)
etomoxir (Supplementary Concept)
antibiotic 1233A (Supplementary Concept)
manumycin (Supplementary Concept)
allosamidin (Supplementary Concept)
tin mesoporphyrin (Supplementary Concept)
RS 5186 (Supplementary Concept)
2'-deoxy-2'-methylenecytidine (Supplementary Concept)
acetovanillone (Supplementary Concept)
ML 9 (Supplementary Concept)
nafagrel (Supplementary Concept)
pseudohypericin (Supplementary Concept)
fumonisin B1 (Supplementary Concept)
nitecapone (Supplementary Concept)
KT 5720 (Supplementary Concept)
bafilomycin A (Supplementary Concept)
cyanoginosin LR (Supplementary Concept)
mofegiline (Supplementary Concept)
phenethyl isothiocyanate (Supplementary Concept)
calphostin C (Supplementary Concept)
calyculin A (Supplementary Concept)
miglustat (Supplementary Concept)
fantofarone (Supplementary Concept)
ICI 198583 (Supplementary Concept)
tyrphostin 47 (Supplementary Concept)
ridogrel (Supplementary Concept)
tyrphostin A23 (Supplementary Concept)
ST 638 (Supplementary Concept)
liarozole (Supplementary Concept)
calphostin complex (Supplementary Concept)
5-fluoro-2'-deoxycytidine 5'-monophosphate (Supplementary Concept)
C6-(N1-methyl-1,2,3-trazolylmethylene)penem (Supplementary Concept)
N,N-dimethylsphingosine (Supplementary Concept)
FK 409 (Supplementary Concept)
lavendustin A (Supplementary Concept)
KN 62 (Supplementary Concept)
5'-thioadenosine (Supplementary Concept)
lobucavir (Supplementary Concept)
KT 5926 (Supplementary Concept)
Ro 31-7549 (Supplementary Concept)
Ro 31-8220 (Supplementary Concept)
N-acetylsphingosine (Supplementary Concept)
FR 74366 (Supplementary Concept)
O(6)-benzylguanine (Supplementary Concept)
N(G)-iminoethylornithine (Supplementary Concept)
SQ 28603 (Supplementary Concept)
beta-lactamase-inhibitor protein, Streptomyces (Supplementary Concept)
kifunensine (Supplementary Concept)
MDL 73811 (Supplementary Concept)
salvianolic acid A (Supplementary Concept)
deslorelin (Supplementary Concept)
zopolrestat (Supplementary Concept)
methyl 2,5-dihydroxycinnamate (Supplementary Concept)
N-acetyl-S-farnesylcysteine (Supplementary Concept)
AG 127 (Supplementary Concept)
PD 128042 (Supplementary Concept)
norcantharidin (Supplementary Concept)
bisindolylmaleimide I (Supplementary Concept)
ML 7 (Supplementary Concept)
aureobasidin A (Supplementary Concept)
Ro 31-8425 (Supplementary Concept)
8-amino-2'-nordeoxyguanosine (Supplementary Concept)
BOF 4272 (Supplementary Concept)
eniluracil (Supplementary Concept)
phosphoprotein phosphatase inhibitor 1 (Supplementary Concept)
RB 101 (Supplementary Concept)
3,4,5-trihydroxybenzamidoxime (Supplementary Concept)
squalestatin 1 (Supplementary Concept)
pervanadate (Supplementary Concept)
nitisinone (Supplementary Concept)
microcystin (Supplementary Concept)
zaragozic acid C (Supplementary Concept)
patuletin (Supplementary Concept)
quercetagetin (Supplementary Concept)
1843U89 (Supplementary Concept)
tyrphostin 25 (Supplementary Concept)
7-nitroindazole (Supplementary Concept)
glucokinase regulatory protein (Supplementary Concept)
Go 6976 (Supplementary Concept)
PGIP protein, plant (Supplementary Concept)
arachidonyltrifluoromethane (Supplementary Concept)
4-amidinoindan-1-one 2'-amidinohydrazone (Supplementary Concept)
trehalose-6-phosphate (Supplementary Concept)
sodium-potassium ATPase inhibitory factor (Supplementary Concept)
rottlerin (Supplementary Concept)
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (Supplementary Concept)
Rum1 protein, S pombe (Supplementary Concept)
tezacitabine (Supplementary Concept)
thiocitrulline (Supplementary Concept)
S-methylthiocitrulline (Supplementary Concept)
3-chlorotyrosine (Supplementary Concept)
SR 31747 (Supplementary Concept)
estrone-3-O-sulfamate (Supplementary Concept)
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline (Supplementary Concept)
olomoucine (Supplementary Concept)
N(6)-(1-iminoethyl)lysine (Supplementary Concept)
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate (Supplementary Concept)
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole (Supplementary Concept)
NB 506 (Supplementary Concept)
farnesylthiosalicylic acid (Supplementary Concept)
isovanillin (Supplementary Concept)
SB 203580 (Supplementary Concept)
marinobufagenin (Supplementary Concept)
3,5-diethoxy-4-aminomethylpyridine (Supplementary Concept)
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (Supplementary Concept)
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide (Supplementary Concept)
dehydroaltenusin (Supplementary Concept)
FTI 277 (Supplementary Concept)
synaptojanin (Supplementary Concept)
ruboxistaurin (Supplementary Concept)
nolatrexed (Supplementary Concept)
ISIS 5132 (Supplementary Concept)
eritadenine (Supplementary Concept)
2-mercaptoethylguanidine (Supplementary Concept)
marimastat (Supplementary Concept)
RTKI cpd (Supplementary Concept)
methyl arachidonylfluorophosphonate (Supplementary Concept)
N-(3-(aminomethyl)benzyl)acetamidine (Supplementary Concept)
2-(allylthio)pyrazine (Supplementary Concept)
DMP 777 (Supplementary Concept)
Y 27632 (Supplementary Concept)
caspase-activated DNase inhibitor (Supplementary Concept)
U 0126 (Supplementary Concept)
arachidonoylethylene glycol (Supplementary Concept)
ranirestat (Supplementary Concept)
lonafarnib (Supplementary Concept)
fukinolic acid (Supplementary Concept)
monastrol (Supplementary Concept)
BGP 15 (Supplementary Concept)
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole (Supplementary Concept)
CP 320626 (Supplementary Concept)
peramivir (Supplementary Concept)
ABT 702 (Supplementary Concept)
(2-boronoethyl)-cysteine (Supplementary Concept)
corydaline (Supplementary Concept)
pritelivir (Supplementary Concept)
Gckr protein, mouse (Supplementary Concept)
3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene (Supplementary Concept)
8-methoxy-2'-deoxyguanosine (Supplementary Concept)
FYX-051 (Supplementary Concept)
saracatinib (Supplementary Concept)
imetelstat (Supplementary Concept)
cetilistat (Supplementary Concept)
(2-(4-(2-benzimidazol-2ylthio)ethyl)piperazin-1yl)-N-(2,4-bis(methylthio)-6-methyl-3-pyridyl)acetamide (Supplementary Concept)
obatoclax (Supplementary Concept)
eliglustat (Supplementary Concept)
alpha,beta-methyleneadenosine 5'-diphosphate (Supplementary Concept)
dibenzazepine (Supplementary Concept)
tosedostat (Supplementary Concept)
pevonedistat (Supplementary Concept)
Ku 0063794 (Supplementary Concept)
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (Supplementary Concept)
adavosertib (Supplementary Concept)
idelalisib (Supplementary Concept)
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea (Supplementary Concept)
islatravir (Supplementary Concept)
6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid (Supplementary Concept)
PF-543 (Supplementary Concept)
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (Supplementary Concept)
LGK974 (Supplementary Concept)
indeno(1,2-b)indole-10-one (Supplementary Concept)
N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (Supplementary Concept)
peficitinib (Supplementary Concept)
venglustat (Supplementary Concept)
(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (Supplementary Concept)
1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione (Supplementary Concept)
2-((1S)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (Supplementary Concept)
TAM16 compound (Supplementary Concept)
IPR19 compound (Supplementary Concept)
2,4-dioxo-N-(4-(4-pyridyl)phenyl)-1H-quinazoline-6-sulfonamide (Supplementary Concept)
N-((2S,3S)-4,4-difluoro-3-hydroxy-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(morpholinomethyl)phenyl)ethynyl)benzamide (Supplementary Concept)
quinuclidin-3-yl-N-(1-(3-(4-fluorophenyl)phenyl)-1-methyl-ethyl)carbamate (Supplementary Concept)
1,2,4-triazolo-(3,4-b)-1,3,4-thiadiazoles (Supplementary Concept)
2,5-dideoxy-2,5-imino-altritol 1,6- bisphosphate (Supplementary Concept)
PC-786 (Supplementary Concept)
PR5-LL-CM01 (Supplementary Concept)
BMH-21 (Supplementary Concept)
RLM001 (Supplementary Concept)
YLC2-155 (Supplementary Concept)
3-(1H-indol-3-yl)-2,3-dihydro-4H-furo(3,2-c)chromen-4-one (Supplementary Concept)
LPC-058 (Supplementary Concept)
gladiolin (Supplementary Concept)
simplifungin (Supplementary Concept)
valsafungin (Supplementary Concept)
serabelisib (Supplementary Concept)
3-amino-2,3-dihydropyrid-4-one (Supplementary Concept)
6-((4-chlorophenyl)methyl)-4-hydroxy-2,3-dihydropyridazin-3-one (Supplementary Concept)
CM544 (Supplementary Concept)
NP16 compound (Supplementary Concept)
kushenol A (Supplementary Concept)
ivosidenib (Supplementary Concept)
BJ-1301 (Supplementary Concept)
LP0040 (Supplementary Concept)
N-phenylpyrrolamide (Supplementary Concept)
LDD2269 (Supplementary Concept)
LY3031207 (Supplementary Concept)
5',8'-dihydroxy-6,6'-dimethyl-7,3'-binaphthyl-1,4,1',4'-tetraone (Supplementary Concept)
5',8'-dihydroxy-5,8-dimethoxy-6,6'-dimethyl-7,3'-binaphthyl-1,4,1',4'-tetraone (Supplementary Concept)
BJJF078 (Supplementary Concept)
ERW1041E (Supplementary Concept)
huperphlegmine B (Supplementary Concept)
huperphlegmine A (Supplementary Concept)
CB-1158 (Supplementary Concept)
KY-226 (Supplementary Concept)
VH298 (Supplementary Concept)
LQFM166 (Supplementary Concept)
4-methyl-2-((2-methylbenzyl) amino)-1,3-thiazole-5-carboxylic acid (Supplementary Concept)
DFP-10825 (Supplementary Concept)
baloxavir (Supplementary Concept)
imarikiren hydrochloride (Supplementary Concept)
dihydrobenzisoxazole-4-one (Supplementary Concept)
Umibecestat (Supplementary Concept)
pyragrel (Supplementary Concept)
4-(5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl)benzonitrile (Supplementary Concept)
2-(phenyl)amino-aceto-hydrazide (Supplementary Concept)
2-(phenylamino)aceto-hydrazide (Supplementary Concept)
STNM01 (Supplementary Concept)
DC_MO1 (Supplementary Concept)
S009-0629 (Supplementary Concept)
PL265 (Supplementary Concept)
firsocostat (Supplementary Concept)
3-(7-azaindolyl)-4-indolylmaleimides (Supplementary Concept)
3-bis((2,5-dioxo-1-(4-((E)-2-phenyldiazen-1-yl)phenyl)pyrrolidin-3-yl)sulfanyl) butanedioic acid (Supplementary Concept)
PCC0208009 (Supplementary Concept)
callyspongiamide A (Supplementary Concept)
callyspongiamide B (Supplementary Concept)
ZGN-1061 (Supplementary Concept)
butaselen (Supplementary Concept)
3(S)-thiomethyl pyrrolidine (Supplementary Concept)
TP0463518 (Supplementary Concept)
selitrectinib (Supplementary Concept)
pqr620 (Supplementary Concept)
KT203 (Supplementary Concept)
KT195 (Supplementary Concept)
KT182 (Supplementary Concept)
zamicastat (Supplementary Concept)
linrodostat (Supplementary Concept)
GDC-0084 (Supplementary Concept)
3-(((16beta,17beta)-3-(2-bromoethyl)-17-hydroxyestra-1,3,5(10)-trien-16-yl)methyl)benzamide (Supplementary Concept)
JNJ-64619178 (Supplementary Concept)
GSK-3326595 (Supplementary Concept)
VSW1198 (Supplementary Concept)
ASP8477 (Supplementary Concept)
JNJ-42165279 (Supplementary Concept)
N-hydroxypyridinedione (Supplementary Concept)
N-hydroxyisoquinolinedione (Supplementary Concept)
LB100 (Supplementary Concept)
fulacimstat (Supplementary Concept)
NAAA inhibitor F215 (Supplementary Concept)
petesicatib (Supplementary Concept)
heclin (Supplementary Concept)
pulrodemstat besilate (Supplementary Concept)
QYM201 (Supplementary Concept)
tirbanibulin (Supplementary Concept)
H3B-120 (Supplementary Concept)
PDE7 inhibitor S14 (Supplementary Concept)
thiamidol (Supplementary Concept)
IMP-1088 (Supplementary Concept)
Acetyldigitoxins (MeSH Term)
Acetyldigoxins (MeSH Term)
Allopurinol (MeSH Term)
Amanitins (MeSH Term)
Aminooxyacetic Acid (MeSH Term)
Amitrole (MeSH Term)
Atractyloside (MeSH Term)
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride (MeSH Term)
Azacitidine (MeSH Term)
Benserazide (MeSH Term)
Benzoflavones (MeSH Term)
Dicumarol (MeSH Term)
Brocresine (MeSH Term)
Cantharidin (MeSH Term)
Cardiac Glycosides (MeSH Term)
Chloromercuribenzoates (MeSH Term)
4-Chloromercuribenzenesulfonate (MeSH Term)
Clavulanic Acids (MeSH Term)
Coformycin (MeSH Term)
Curcumin (MeSH Term)
Cyclosporins (MeSH Term)
Cystamine (MeSH Term)
Desipramine (MeSH Term)
Deslanoside (MeSH Term)
Dichlororibofuranosylbenzimidazole (MeSH Term)
Digitalis Glycosides (MeSH Term)
Digitoxin (MeSH Term)
Digoxin (MeSH Term)
Erythromycin Estolate (MeSH Term)
Ethacrynic Acid (MeSH Term)
Ethidium (MeSH Term)
Ethylmaleimide (MeSH Term)
Fusaric Acid (MeSH Term)
Hydroxychloroquine (MeSH Term)
Hydroxymercuribenzoates (MeSH Term)
Hydroxyurea (MeSH Term)
Iodoacetamide (MeSH Term)
Iodoacetates (MeSH Term)
Medigoxin (MeSH Term)
Mercuribenzoates (MeSH Term)
Mersalyl (MeSH Term)
Methotrexate (MeSH Term)
Methylene Blue (MeSH Term)
Metyrapone (MeSH Term)
Mitoguazone (MeSH Term)
Mycophenolic Acid (MeSH Term)
4-Chloro-7-nitrobenzofurazan (MeSH Term)
Novobiocin (MeSH Term)
o-Phthalaldehyde (MeSH Term)
Oligomycins (MeSH Term)
Ouabain (MeSH Term)
Oxypurinol (MeSH Term)
Fenclonine (MeSH Term)
Pentachlorophenol (MeSH Term)
Phencyclidine (MeSH Term)
Phenylglyoxal (MeSH Term)
Phenylmethylsulfonyl Fluoride (MeSH Term)
Phosphonoacetic Acid (MeSH Term)
Potassium Cyanide (MeSH Term)
Proadifen (MeSH Term)
Proscillaridin (MeSH Term)
Quinacrine (MeSH Term)
Quinidine (MeSH Term)
Rutamycin (MeSH Term)
Sodium Cyanide (MeSH Term)
Strophanthins (MeSH Term)
Trichloroepoxypropane (MeSH Term)
Valproic Acid (MeSH Term)
Meglutol (MeSH Term)
3-Mercaptopropionic Acid (MeSH Term)
4-Hydroxycoumarins (MeSH Term)
Erythromycin Ethylsuccinate (MeSH Term)
Cyclosporine (MeSH Term)
Aphidicolin (MeSH Term)
Lithium Carbonate (MeSH Term)
Swainsonine (MeSH Term)
Annexin A5 (MeSH Term)
1-Deoxynojirimycin (MeSH Term)
Thapsigargin (MeSH Term)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine (MeSH Term)
Palmitic Acid (MeSH Term)
Staurosporine (MeSH Term)
Okadaic Acid (MeSH Term)
omega-N-Methylarginine (MeSH Term)
beta-Naphthoflavone (MeSH Term)
Buthionine Sulfoximine (MeSH Term)
NG-Nitroarginine Methyl Ester (MeSH Term)
Nitroarginine (MeSH Term)
3-Iodobenzylguanidine (MeSH Term)
alpha-Methyltyrosine (MeSH Term)
Iodoacetic Acid (MeSH Term)
Sodium Azide (MeSH Term)
Tyrphostins (MeSH Term)
Vigabatrin (MeSH Term)
Permethrin (MeSH Term)
S-Nitroso-N-Acetylpenicillamine (MeSH Term)
Oseltamivir (MeSH Term)
Zanamivir (MeSH Term)
Atovaquone (MeSH Term)
Pemetrexed (MeSH Term)
Resveratrol (MeSH Term)
Decitabine (MeSH Term)
Terbinafine (MeSH Term)
Caspofungin (MeSH Term)
Leflunomide (MeSH Term)
Orlistat (MeSH Term)
Cidofovir (MeSH Term)
Fomepizole (MeSH Term)
DNA Methyltransferase 3B (MeSH Term)
2',5'-dideoxy-2-fluoroadenosine (Supplementary Concept)
lysine-iodoacetylmethotrexate (Supplementary Concept)
omapatrilat (Supplementary Concept)
MK 0591 (Supplementary Concept)
1,6-dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine (Supplementary Concept)
1-(2-hydroxy-3-nonyl)-1,2,4-triazole (Supplementary Concept)
5-(formylamino)imidazole riboside (Supplementary Concept)
1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide (Supplementary Concept)
3,6,7,8-tetrahydro-3-((2-hydroxyethoxy)methyl)imidazo(4,5-d)(1,3)diazepin-8-ol (Supplementary Concept)
9-(2-hydroxy-3-nonyl)-1-deazaadenine (Supplementary Concept)
(2R,3S)-3-(4-Amino-1H-imidazo(4,5-c)pyridin-1-yl)-2-nonanol (Supplementary Concept)
elapegademase (Supplementary Concept)
2-(2-hydroxydecyl)-4-aminopyrazolo(3,4-d)pyrimidine (Supplementary Concept)
adecypenol (Supplementary Concept)
adechlorin (Supplementary Concept)
(1-hydroxyethyl)-5-methyl-1-beta-ribofuranosylimidazole (Supplementary Concept)
9-(1-hydroxy-2-octyl)adenine (Supplementary Concept)
7-deaza-9-(2-hydroxy-3-nonyl)adenine (Supplementary Concept)
1,3-dideaza-9-(2-hydroxy-3-nonyl)adenine (Supplementary Concept)
1-(4-(5-(3-(4-chlorophenyl)propoxy)-1-methylindol-3-yl)-1-hydroxy-2-butyl)imidazole-4-carboxamide (Supplementary Concept)
1-(2-hydroxy-3-nonyl)imidazole-4-carboxamide (Supplementary Concept)
9-(tetrahydro-2-furyl)-adenine (Supplementary Concept)
ethyl 5-aminopyrazolo(1,5-a)quinazoline-3-carboxylate (Supplementary Concept)
2',5'-dideoxy-2,5'-difluoroadenosine (Supplementary Concept)
1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- (Supplementary Concept)
7,8-dihydroxy-N,N-didesmethylchlorpromazine (Supplementary Concept)
7,8-dioxo-N,N-didesmethylchlorpromazine (Supplementary Concept)
5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol (Supplementary Concept)
2',3'-O-(N-methylanthraniloyl)inosine 5'-triphosphate (Supplementary Concept)
NSD 1034 (Supplementary Concept)
2,3-methano-3-tyrosine (Supplementary Concept)
2,3,4-trihydroxybenzylhydrazine (Supplementary Concept)
5-(3,4-dihydroxycinnamoyl)salicylic acid (Supplementary Concept)
RCAN2 protein, human (Supplementary Concept)
TBC1D10C protein, mouse (Supplementary Concept)
6-(3,4-dichlorophenyl)-4-(N,N-dimethylaminoethylthio)-2-phenylpyrimidine (Supplementary Concept)
pimecrolimus (Supplementary Concept)
SCY-641 (Supplementary Concept)
brinzolamide (Supplementary Concept)
dorzolamide (Supplementary Concept)
N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide (Supplementary Concept)
sezolamide (Supplementary Concept)
L 685393 (Supplementary Concept)
entacapone (Supplementary Concept)
5-hydroxy-3-mercapto-4-methoxybenzoic acid (Supplementary Concept)
3-(3-hydroxy-4-methoxy-5-nitrobenzylidene)-2,4-pentanedione (Supplementary Concept)
methylspinazarin (Supplementary Concept)
OR486 (Supplementary Concept)
salsolidine (Supplementary Concept)
1-carboxysalsoline (Supplementary Concept)
3,4-dihydroxy-5-nitrobenzophenone (Supplementary Concept)
3,4-dihydroxy-2-nitrobenzophenone (Supplementary Concept)
opicapone (Supplementary Concept)
N-(3,4-dihydroxyphenyl)maleimide (Supplementary Concept)
2,5-hexanedione (Supplementary Concept)
normeperidine (Supplementary Concept)
phosalone (Supplementary Concept)
phoxim (Supplementary Concept)
demecarium (Supplementary Concept)
distigmine (Supplementary Concept)
2-chloro-12-(2-piperidinoethyl)dibenzo(d,g)-1,3,6-dioxazocine (Supplementary Concept)
physostigmine heptyl (Supplementary Concept)
1,10-phenanthroline (Supplementary Concept)
O,O'-(3-methyl)phenylenediphorylchloride (Supplementary Concept)
N,N'-(3-methyl)phenylenediaminophosphorylchloridate (Supplementary Concept)
(9-amino-5,6,7,8-tetrahydroacridin-4-yl)methanol (Supplementary Concept)
TZ2PA6 compound (Supplementary Concept)
Z 338 (Supplementary Concept)
AP 2238 (Supplementary Concept)
14-norhuperzine A (Supplementary Concept)
velnacrine (Supplementary Concept)
methanesulfonyl fluoride (Supplementary Concept)
alternariol (Supplementary Concept)
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (Supplementary Concept)
fasciculin (Supplementary Concept)
phenserine (Supplementary Concept)
octamethyl pyrophosphoramide (Supplementary Concept)
3-hydroxy-2-oxoindole (Supplementary Concept)
tabun (Supplementary Concept)
VX (Supplementary Concept)
huperzine A (Supplementary Concept)
6,10,14-trimethylpentadeca-5,10-dien-2,12-dione (Supplementary Concept)
ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate (Supplementary Concept)
6-(ethyl-(2-methoxybenzyl)amino)-1-(1'-(6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)-(4,4')bipiperidinyl-1-yl)hexan-1-one (Supplementary Concept)
bis(18)-huperzine B (Supplementary Concept)
isosarcodine (Supplementary Concept)
N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-N'-(4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl)acetamide (Supplementary Concept)
3-methyl-2-(4-methyl-1-piperazinyl)-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)quinoline-4-carboxamide (Supplementary Concept)
acetylsalicylic acid lysinate (Supplementary Concept)
fenbufen (Supplementary Concept)
proquazone (Supplementary Concept)
indobufen (Supplementary Concept)
sinapaldehyde (Supplementary Concept)
DuP 697 (Supplementary Concept)
1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine (Supplementary Concept)
licofelone (Supplementary Concept)
1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole (Supplementary Concept)
sulindac sulfone (Supplementary Concept)
tenoxicam (Supplementary Concept)
ebselen (Supplementary Concept)
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide (Supplementary Concept)
L 778736 (Supplementary Concept)
SC 299 (Supplementary Concept)
7-methoxy-alpha-methyl-2-naphthaleneacetic acid (Supplementary Concept)
deracoxib (Supplementary Concept)
6-ethoxy-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-one (Supplementary Concept)
mofezolac (Supplementary Concept)
Ethonium (Supplementary Concept)
salicin (Supplementary Concept)
tenidap (Supplementary Concept)
LQFM-091 (Supplementary Concept)
1-(4-chlorobenzoyl)-3-(2-(1H-imidazol-1-yl)-2-oxoethyl)-5-methoxy-2-methyl-1H-indole (Supplementary Concept)
N-succinimidyl-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (Supplementary Concept)
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide (Supplementary Concept)
phenidone (Supplementary Concept)
L 745337 (Supplementary Concept)
nimesulide (Supplementary Concept)
flosulide (Supplementary Concept)
Magnesium Salicylate (Supplementary Concept)
SC 560 (Supplementary Concept)
valdecoxib (Supplementary Concept)
((E)-(5)-(3,5-di-tert-butyl-4-hydroxybenzylidene)- 2-ethyl-1,2-isothiazolidine-1,1-dioxide) (Supplementary Concept)
parecoxib (Supplementary Concept)
lumiracoxib (Supplementary Concept)
2-hydroxymethyl-4-(5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl)-1-benzenesulfonamide (Supplementary Concept)
dual inhibitor PTUPB (Supplementary Concept)
rofecoxib (Supplementary Concept)
3-((cyclohexylmethyl)(3,3-dimethylbutyl)amino)-2-(4-(trifluoromethyl)phenyl)cyclohexyl)acetic acid (Supplementary Concept)
ELN594 (Supplementary Concept)
SPI-1865 (Supplementary Concept)
LY900009 (Supplementary Concept)
24-diamino-5-phenylthiazole (Supplementary Concept)
2-(3-(3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)phenyl) -8-(3,4,5-trifluorophenoxy)-5,6,7,8-tetrahydro(1,2,4)triazolo(4,3-a)pyridin-8-yl)propan-2-ol (Supplementary Concept)
7-(4-fluorophenyl)-N2-(3-methoxy-4-(3-methyl-1H-1,2,4-triazol-1-yl)phenyl)-N4-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidine-2,4-diamine (Supplementary Concept)
BPN-15606 (Supplementary Concept)
cyclohexyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Supplementary Concept)
FRM-36143 (Supplementary Concept)
BMS-986115 (Supplementary Concept)
tarenflurbil (Supplementary Concept)
MRK 560 (Supplementary Concept)
L 685458 (Supplementary Concept)
benzyloxycarbonyl-leucyl-leucyl-norleucinal (Supplementary Concept)
benzyloxycarbonyl-isoleucyl-leucinal (Supplementary Concept)
MRK 003 (Supplementary Concept)
2-(((3,5-difluorophenyl)acetyl)amino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide (Supplementary Concept)
3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)butyramide (Supplementary Concept)
N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide (Supplementary Concept)
nirogacestat (Supplementary Concept)
BMS 708163 (Supplementary Concept)
3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid (Supplementary Concept)
1-(1-(4-fluorophenyl)ethyl)-3-((3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)methylene)-2-piperidinone (Supplementary Concept)
SCH 1500022 (Supplementary Concept)
2-(3,5-bis(4-(trifluoromethyl)phenyl)phenyl)-4-methylpentanoic acid (Supplementary Concept)
(1-(4-methyl-1-(6-(trifluoromethyl)-3-pyridinyl)pentyl)-2-(4-(trifluoromethyl)phenyl)-4-piperidinyl)acetic acid (Supplementary Concept)
AZ4800 (Supplementary Concept)
AZ1136 (Supplementary Concept)
AZ3303 (Supplementary Concept)
BIIB042 (Supplementary Concept)
(R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo(4,3-c)quinoline (Supplementary Concept)
2-(N-((3-(1,2,4-oxadiazol-3-yl)bicyclo(1.1.1)pentan-1-yl)methyl)-4-chlorophenylsulfonamido)-5,5,5-trifluoropentanamide (Supplementary Concept)
2-(2-(3,5-difluorophenyl)-acetylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)propionamide (Supplementary Concept)
curcumin-phenylalanine (Supplementary Concept)
curcumin-valine (Supplementary Concept)
1-((1,1,1-trifluoro-7-methyloctan-4-yl)-2-(4-(trifluoromethyl)phenyl)piperidin-4-yl)acetic acid (Supplementary Concept)
SCH 900229 (Supplementary Concept)
2-(5-chloro-6-(2,2,2-trifluoroethoxy)-4'-(trifluoromethyl)biphenyl-3-yl)-3-cyclobutylpropanoic acid (Supplementary Concept)
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester (Supplementary Concept)
MW167 (Supplementary Concept)
begacestat (Supplementary Concept)
2',3',4',5,5',6,7,8,9,10-decahydro-2-(5-(4-fluorophenyl)-1-methylpyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)spiro(6,9-methanobenzocycloocten-11,3'-(1,2,5)thiadiazole) 1',1'-dioxide (Supplementary Concept)
1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid (Supplementary Concept)
2-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(3-methyl-4-oxo-4,5-dihydro-3H-benzo(d)(1,2)diazepin-5-yl)propanamide (Supplementary Concept)
N-(N-(3,5-difluorophenylacetyl)alanyl)phenylglycine 4-benzoylbenzyl amide (Supplementary Concept)
N-((5-(2,4-diamino-6-pteridinyl)ethyl)-2-thenoyl)glutamic acid (Supplementary Concept)
4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo(4,3-c)quinoline (Supplementary Concept)
(S,E)-1-(2-methoxy-4-((4-(3,4,5-trifluorophenyl)-3,4,7,8-tetrahydropyrido(2,1-c)(1,2,4)oxadiazin-9(6H)-ylidene)methyl)phenyl)-4-methyl-1H-imidazol-3-ium-hemi-(E)-3-carboxyacrylate (Supplementary Concept)
voglibose (Supplementary Concept)
conduritol B (Supplementary Concept)
N-nonyl-1-deoxynojirimycin (Supplementary Concept)
salicortin (Supplementary Concept)
5-amino-5-deoxygluconic acid delta-lactam (Supplementary Concept)
trestatin (Supplementary Concept)
dihydroacarbose (Supplementary Concept)
phenyl-6-deoxy-6-(morpholin-4-yl)glucopyranoside (Supplementary Concept)
3-O-digalloyl-1,2,4,6-tetra-O-galloylglucose (Supplementary Concept)
N-phenyl-4,5,6,7-tetrachlorophthalimide (Supplementary Concept)
13-hydroxykompasinol A (Supplementary Concept)
scirpusin C (Supplementary Concept)
acarviosinyl-(1-9)-3-glucopyranosylpropene (Supplementary Concept)
valienamine (Supplementary Concept)
6-methyl-3-hydroxypiperidine-2-carboxylic acid (Supplementary Concept)
rubasperone A (Supplementary Concept)
rubasperone B (Supplementary Concept)
butyl isobutyl phthalate (Supplementary Concept)
1,4-dideoxy-1,4-((2,3,4,5,6-pentahydroxyhexyl)episulfoniumylidene)arabinitol (Supplementary Concept)
pycnalin (Supplementary Concept)
pradimicin Q (Supplementary Concept)
lonchocarpene (Supplementary Concept)
3,5-dimethoxy-4'-O-prenyl-trans-stilbene (Supplementary Concept)
ginnalin A (Supplementary Concept)
jamutannin B (Supplementary Concept)
jamutannin A (Supplementary Concept)
iso-oenothein C (Supplementary Concept)
epigallocatechin-3-O-gallate epigallocatechin dimer (Supplementary Concept)
24,25,26,27-tetranor-apotirucalla-(apoeupha)-1-senecioyloxy-3,7-dihydroxy-14,20,22-trien-21,23-epoxy (Supplementary Concept)
pistagremic acid (Supplementary Concept)
polyflavanostilbene A (Supplementary Concept)
deoxyvalidamine (Supplementary Concept)
2,3,4,5,6-pentagalloylglucose (Supplementary Concept)
4-O-glucopyranosylmoranoline (Supplementary Concept)
nigrosporamide A (Supplementary Concept)
dihydropyrano(3,2-c)quinoline (Supplementary Concept)
dorsilurin F (Supplementary Concept)
schulzeine A (Supplementary Concept)
6-aminocyclohex-4-ene-1,2,3-triol (Supplementary Concept)
purunuside A (Supplementary Concept)
purunuside B (Supplementary Concept)
purunuside C (Supplementary Concept)
isoacarbose (Supplementary Concept)
acarviosine-glucose (Supplementary Concept)
7-deoxycastanospermine (Supplementary Concept)
CM-10-18 compound (Supplementary Concept)
6-amino-pyrido(2,3-d)pyrimidine-2,4-dione (Supplementary Concept)
lamesticumin G (Supplementary Concept)
allyl sulfide (Supplementary Concept)
R 115866 (Supplementary Concept)
BAS 100 (Supplementary Concept)
2,4-undeca-2,4-diene-8,10-diynoic acid isobutylamide (Supplementary Concept)
2-methyl-2-adamantyl 2-methyl-2-(3-pyridyl)propanoate (Supplementary Concept)
1-trityl-4-nitroimidazole (Supplementary Concept)
4-allyloxymethamphetamine (Supplementary Concept)
4-amino-N-(3-methylbut-1-yl)-N-(2-phenyl-2H-pyrazol-3-yl)benzenesulfonamide (Supplementary Concept)
1-(2,4-dimethoxyphenyl)-2-(3,5-dimethoxyphenyl)ethene (Supplementary Concept)
biapigenin (Supplementary Concept)
piperine (Supplementary Concept)
seviteronel (Supplementary Concept)
6',7'-dihydroxybergamottin (Supplementary Concept)
CB 7645 (Supplementary Concept)
tetcyclasis (Supplementary Concept)
tioconazole (Supplementary Concept)
posaconazole (Supplementary Concept)
fosfluconazole (Supplementary Concept)
frutinone A (Supplementary Concept)
furafylline (Supplementary Concept)
efavirenz (Supplementary Concept)
amentoflavone (Supplementary Concept)
Baoyuan decoction (Supplementary Concept)
1-((2-ethyl-4-methyl-1H-imidazol-5-yl)methyl)-4-(4-(trifluoromethyl)-2-pyridinyl)piperazine (Supplementary Concept)
curcumenol (Supplementary Concept)
(7R)-7-hydroxytaxiresinol (Supplementary Concept)
2,3-bis(hydroxymethyl)-7-hydroxy-6-methoxy-1-tetralone (Supplementary Concept)
(3S,4R)-4'-hydroxy-6,3'-dimethoxyisoflavan-4-ol (Supplementary Concept)
cobicistat mixture with darunavir (Supplementary Concept)
2,4-diamino-5-adamantyl-6-methylpyrimidine (Supplementary Concept)
10-deazaaminopterin (Supplementary Concept)
methylbenzoprim (Supplementary Concept)
gamma-methylene-10-deazaaminopterin (Supplementary Concept)
gamma-methylene-10-ethyl-10-deazaaminopterin (Supplementary Concept)
ethylbenzoprim (Supplementary Concept)
2,4-diamino-5-((3,5-dichloro-4-(1-pyrrolo)anilino)methyl)-6-bromothieno(2,3-d)pyrimidine (Supplementary Concept)
2,4-diamino-5,6,7,8-tetrahydro-7-(4'-benzoylglutamic acid)pyrido(4',3'-4,5)furo(2,3-d)pyrimidine (Supplementary Concept)
BRL 6231 (Supplementary Concept)
3'-fluoroaminopterin (Supplementary Concept)
2'-fluoroaminopterin (Supplementary Concept)
(N-(4-amino-4-deoxy-N(10)-methylpteroyl)amino)-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (Supplementary Concept)
cycloguanil (Supplementary Concept)
2,4-diamino-5,6-dihydro-6,6-dimethyl-5-(4'-methoxyphenyl)-s-triazine (Supplementary Concept)
edatrexate (Supplementary Concept)
5-deazamethotrexate (Supplementary Concept)
5-deazafolic acid (Supplementary Concept)
5-deazaaminopterin (Supplementary Concept)
N-(4-((2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)thio)benzoyl)glutamic acid (Supplementary Concept)
N-(4-((2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)thio)benzoyl)glutamic acid (Supplementary Concept)
N-((2,4-diaminopteridin-6-yl)methyl)dibenz(b,f)azepine (Supplementary Concept)
N-(2-amino-4-ethyl((pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)glutamic acid (Supplementary Concept)
N-(2-amino-4-ethyl-6-methyl((pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)glutamic acid (Supplementary Concept)
N-(4-((2,4-diaminoquinazoline-6-yl)methylene)oxycarbonyl)benzoyl glutamic acid (Supplementary Concept)
2,4-diamino-6-((2',5'-dichloroanilino)methyl)pyrido(2,3-d)pyrimidine (Supplementary Concept)
2,4-diamino-6-((3',4',5'-trichloroanilino)methyl)pyrido(2,3-d)pyrimidine (Supplementary Concept)
2,4-diamino-5-(2'-(4-carboxyphenyl)ethynyl)-5'-(methoxybenzyl)pyrimidine (Supplementary Concept)
piritrexim (Supplementary Concept)
3-azidopyrimethamine (Supplementary Concept)
3',5'-dichloromethotrexate (Supplementary Concept)
M and B 35769 (Supplementary Concept)
lometrexol (Supplementary Concept)
4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-phenylthiomethylphenyl)-1,3,5-triazine (Supplementary Concept)
2,4-diamino-6-((3',4',5'-trimethoxy-N-methylanilino)methyl)pyrido(3,2-d)pyrimidine (Supplementary Concept)
2,4-diamino-5-(4-fluoro-3-nitrophenyl)-6-ethylpyrimidine (Supplementary Concept)
aditoprim (Supplementary Concept)
2,4-diamino-5-(3-(3-(2-(acetyloxy)ethyl)-3-benzyltriazen-1-yl)-4-chlorophenyl)-6-ethylpyrimidine (Supplementary Concept)
iclaprim (Supplementary Concept)
BW 1540 (Supplementary Concept)
BW 2315 (Supplementary Concept)
2,4-diamino-6-(2'-O-(3-carboxypropyl)oxydibenz(b,f)azepin-5-yl)methylpteridine (Supplementary Concept)
2,4-diamino-5-methyl-6-(2',5'-dimethoxyphenylthio)pyrrolo(2,3-d)pyrimidine (Supplementary Concept)
2,4-diamino-6-(N-(2',5'-dimethoxybenzyl)-N-methylamino)pyrido(2,3-d)pyrimidine (Supplementary Concept)
raltitrexed (Supplementary Concept)
7-hydroxymethotrexate (Supplementary Concept)
triazinate (Supplementary Concept)
bexarotene hydroxamic acid (Supplementary Concept)
apicidin (Supplementary Concept)
romidepsin (Supplementary Concept)
carboxycinnamic acid bishydroxamide (Supplementary Concept)
CKD-581 (Supplementary Concept)
SW-100 (Supplementary Concept)
AES-135 (Supplementary Concept)
CAY10603 (Supplementary Concept)
givinostat hydrochloride (Supplementary Concept)
N-hydroxy-4-(3-methyl-2-phenylbutyrylamino)benzamide (Supplementary Concept)
SD-0203 (Supplementary Concept)
SD-2007 (Supplementary Concept)
5-nitroso-8-quinolinol (Supplementary Concept)
scriptaid (Supplementary Concept)
mocetinostat (Supplementary Concept)
butyroyloxymethyl 4-phenylbutyrate (Supplementary Concept)
N-hydroxy-3-(3-(1H-indole-2-carbonyl)phenyl)acrylamide (Supplementary Concept)
3-(3-(benzofuran-2-carbonyl)phenyl)-N-hydroxyacrylamide (Supplementary Concept)
3-(3-(3-(3-chlorophenyl)-3-oxopropenyl)-1-methylpyrrol-2-yl)propenoic hydroxamic acid (Supplementary Concept)
5-((6-(3-chlorophenyl)-4-oxo-3H-pyrimidin-2-yl)thio)pentanoic hydroxamic acid (Supplementary Concept)
R 306465 (Supplementary Concept)
metacept-1 (Supplementary Concept)
ACS2 compound (Supplementary Concept)
ACS33 compound (Supplementary Concept)
ixazomib (Supplementary Concept)
spiruchostatin B (Supplementary Concept)
triciferol (Supplementary Concept)
7-phenyl-2,4,6-heptatrienoylhydroxamic acid (Supplementary Concept)
N-hydroxy-3-(2-oxo-1-phenethyl-1,2,5,6-tetrahydropyridin-3-yl)propanamide (Supplementary Concept)
N1-(2-aminophenyl)-N7-phenylheptanediamide (Supplementary Concept)
4-dimethylamino-N-(5-(2-mercaptoacetylamino)pentyl)benzamide (Supplementary Concept)
PD 123244-15 (Supplementary Concept)
3-(1-methyl-4-phenylacetyl-1H-2-pyrrolyl)-N-hydroxypropenamide (Supplementary Concept)
7-(4-(4-cyanophenyl)phenoxy)heptanohydroxamic acid (Supplementary Concept)
tubacin (Supplementary Concept)
4-dimethylamino-N-(4-(2-hydroxycarbamoylvinyl)benzyl)benzamide (Supplementary Concept)
N-(4-(2-hydroxycarbamoylvinyl)benzyl)-4-pyrrolidin-1-ylbenzamide (Supplementary Concept)
N-hydroxy-4-(4-phenylbutyrylamino)benzamide (Supplementary Concept)
WT161 (Supplementary Concept)
LG325 (Supplementary Concept)
WMJ-8-B (Supplementary Concept)
tacedinaline (Supplementary Concept)
ricolinostat (Supplementary Concept)
abexinostat (Supplementary Concept)
cyclic hydroxamic acid-containing peptide 1 (Supplementary Concept)
4-(dimethylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide (Supplementary Concept)
CKD-506 (Supplementary Concept)
LMK-235 (Supplementary Concept)
A452 compound (Supplementary Concept)
marbostat-100 (Supplementary Concept)
HKI 46F08 (Supplementary Concept)
KBH A42 (Supplementary Concept)
3-(1-cinnamyl-1H-1,2,3-triazol-4-yl)-N-hydroxyacrylamide (Supplementary Concept)
N1-(2-aminophenyl)-N4-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)terephthalamide (Supplementary Concept)
N2-(2-aminophenyl)-N5-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)thiophene-2,5-dicarboxamide (Supplementary Concept)
4-(3-(hydroxyamino)-3-oxoprop-1-enyl)-N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)benzamide (Supplementary Concept)
citarinostat (Supplementary Concept)
CRA 026440 (Supplementary Concept)
N1-(2-aminophenyl)-N8-phenyloctanediamide (Supplementary Concept)
O-n-butanoyl-2,3-O-isopropylidenemannofuranoside (Supplementary Concept)
N-hydroxy-7-(2-naphthylthio)heptanamide (Supplementary Concept)
N-(2-aminophenyl)-4-((benzyl(2-hydroxyethyl)amino)methyl) benzamide (Supplementary Concept)
azelaic bishydroxamic acid (Supplementary Concept)
scriptide (Supplementary Concept)
belinostat (Supplementary Concept)
thioisobutyric acid S-(6-(4-phenyl-2-thiazolylcarbamoyl)hexyl) ester (Supplementary Concept)
entinostat (Supplementary Concept)
trapoxin A (Supplementary Concept)
santacruzamate A (Supplementary Concept)
animacroxam (Supplementary Concept)
trichostatin A (Supplementary Concept)
L 645164 (Supplementary Concept)
phosphoadenosine diphosphoribose (Supplementary Concept)
6-(2-(8-((4-fluorobenzyl)oxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthyl)ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one (Supplementary Concept)
pannorin (Supplementary Concept)
3,25-dihydroxycholest-8(14)-en-15-one (Supplementary Concept)
3-hydroxy-24-dimethylaminochol-8(14)-en-15-one (Supplementary Concept)
RP 61969 (Supplementary Concept)
L 157012 (Supplementary Concept)
rupintrivir (Supplementary Concept)
L 647318 (Supplementary Concept)
BMY 21950 (Supplementary Concept)
3-hydroxy-25,26,26,26,27,27,27-heptafluoro-5-cholest-8(14)-en-15-one (Supplementary Concept)
7-(3-bromo-4,5-bis(4-fluorophenyl)-2-(1-methylethyl)-1H-pyrrol-1-yl)-3,5-dihydroxy-6-heptenoic acid methyl ester (Supplementary Concept)
7-(7-((1,1'-biphenyl-4-yl)methyl)-2-(4-fluorophenyl)-4,5,6,7-tetrahydro-2H-indazol-3-yl)-3,5-dihydroxy-6-heptenoic acid (Supplementary Concept)
7-(3-hydroxy-2-methyl-1,2,3,5,6,7,8,8a-octahydro-1-naphtalenyl)-3,5-dihydroxyheptanoic acid (Supplementary Concept)
cerivastatin (Supplementary Concept)
GR 95030X (Supplementary Concept)
2-(2-(3-hydroxy-12-(2-methyl-1-oxobutoxy)-5-androstan-17-yl)ethyl)tetrahydro-4-hydroxy-2H-pyran-6-one (Supplementary Concept)
2,6,7-trideoxy-7-C-(2,4-dichlorophenyl)heptonic acid (Supplementary Concept)
6-(2,4-dichlorophenyl)-2,3,4-trihydroxyhexanesulfonic acid (Supplementary Concept)
7-(2,4-dichlorophenyl)-3-hydroxy-5-heptanolide (Supplementary Concept)
6-(2,4-dichlorophenyl)-2,4-dihydroxyhexane-1-sulfonic acid (Supplementary Concept)
6-(2,4-dichlorophenyl)-erythro-2,4-dihydroxyhexylphosphonic acid (Supplementary Concept)
3-hydroxycholest-8(14),24-dien-15-one (Supplementary Concept)
3,24-dihydroxycholest-8(14)-en-15-one (Supplementary Concept)
GR 92549 (Supplementary Concept)
pitavastatin (Supplementary Concept)
6-hydroxyisocompactin (Supplementary Concept)
SRI 62320 (Supplementary Concept)
3,4-dihydroxyphenylpropionylleucinamide (Supplementary Concept)
dihydromevinolin (Supplementary Concept)
dihydrocompactin (Supplementary Concept)
fermodulin (Supplementary Concept)
6-(2-(2,4-dichloro-6-hydroxyphenyl)ethyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one (Supplementary Concept)
cholest-8-ene-3,15-diol (Supplementary Concept)
HR 780 (Supplementary Concept)
crilvastatin (Supplementary Concept)
chrysosporin (Supplementary Concept)
7-(2'-((2''-methyl-1''-oxobutoxy)methyl)-1'-cyclohexyl)-3-hydroxy-5-oxoheptanoic acid (Supplementary Concept)
lanost-8-en-3-ol-24-one (Supplementary Concept)
methoxypolyethoxylated cholesterol (Supplementary Concept)
amlodipine, atorvastatin drug combination (Supplementary Concept)
red yeast rice (Supplementary Concept)
SQ 33600 (Supplementary Concept)
L 669262 (Supplementary Concept)
mevastatin (Supplementary Concept)
elvitegravir (Supplementary Concept)
3,5-dicaffeoylquinic acid (Supplementary Concept)
chicoric acid (Supplementary Concept)
aspochalasin L (Supplementary Concept)
dolutegravir (Supplementary Concept)
EBR28 peptide (Supplementary Concept)
BMS-707035 (Supplementary Concept)
7-(3,4-dichlorobenzyl)-5,9-dihydroxypyrrolo(3,4-g)quinoxaline-6,8-dione (Supplementary Concept)
7-(4-chlorobenzyl)-5,9-dihydroxypyrrolo(3,4-g)quinoxaline-6,8-dione (Supplementary Concept)
cabotegravir (Supplementary Concept)
MUT-A compound (Supplementary Concept)
INRAT10b (Supplementary Concept)
ceftolozane, tazobactam drug combination (Supplementary Concept)
avibactam, ceftazidime drug combination (Supplementary Concept)
olivacins (Supplementary Concept)
brobactam (Supplementary Concept)
3-chloro-3',3'-dimethyl-7'-oxo-3-((phenylamino)carbonyl)spiro(oxirane-2,6'-(4)thia(1)azabicyclo(3.2.)heptane)-2'-carboxylic acid (Supplementary Concept)
methylene-6-(3-formylallylidene)penicillanate pivalate (Supplementary Concept)
pluracidomycin (Supplementary Concept)
6-beta-(trifluoromethanesulfonyl)amido-penicillanic acid sulfone (Supplementary Concept)
3-(2-cyanoethenyl)-3-methyl-4,4,7-trioxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid (Supplementary Concept)
2-(ethoxycarbonyl)-6,6-dihydropenicillanic acid (Supplementary Concept)
3-carboxyphenyl((N-((4-iodophenyl)acetyl)amino)methyl)phosphonate (Supplementary Concept)
SB 202742 (Supplementary Concept)
N-tosyloxy-4-phenyl-2-azetidinone (Supplementary Concept)
N-tosyloxy-3-phthalimido-4-methyl-2-azetidinone (Supplementary Concept)
6-(1-(1-(2-(2-phenyl-1,3,4-thiadiazol-5-yl)thioethyl)-1,2,3-triazol-4-yl)methylene)penicillanic acid (Supplementary Concept)
6-(1-(1-(2--(2-phenyl-1,3,4-thiadiazol-5-yl)sulfonylethyl)-1,2,3-triazol-4-yl)methylene)penicillanic acid (Supplementary Concept)
6-((4-nitrobenzyloxycarbonyl)methylsulfonamido)penicillanic acid sulfone (Supplementary Concept)
6-((anilinocarbonyl)methylsulfonamido)penicillanic acid sulfone (Supplementary Concept)
6-((carboxy)methylsulfonamido)penicillanic acid sulfone (Supplementary Concept)
1-(4-methoxyphenyl)-3-acetamido-4-methoxyazetidin-2-one (Supplementary Concept)
Ro 48-1256 (Supplementary Concept)
L 159906 (Supplementary Concept)
6-chloro-2-chloromethyl-2-methylpenam-3-carboxylic acid 1,1-dioxide (Supplementary Concept)
KA-107 (Supplementary Concept)
6-acetylmethylenepenicillanic acid (Supplementary Concept)
isatoic anhydride (Supplementary Concept)
6-methyl-2-aminopyridine palladium dichloride (Supplementary Concept)
BL-P 2090 (Supplementary Concept)
BL-P 2013 (Supplementary Concept)
dotriacolide (Supplementary Concept)
6-sulfoaminopenicillanic acid (Supplementary Concept)
enmetazobactam (Supplementary Concept)
levonadifloxacin (Supplementary Concept)
Syn 2190 (Supplementary Concept)
benzo(b)thiophene-2-ylboronic acid (Supplementary Concept)
izumenolide (Supplementary Concept)
AM 113 (Supplementary Concept)
AM 114 (Supplementary Concept)
AM 115 (Supplementary Concept)
phenylpropynal (Supplementary Concept)
6-(1-hydroxy)benzylpenicillanic acid S,S-dioxide (Supplementary Concept)
6-(methyoxymethylene)penicillanic acid (Supplementary Concept)
(1S,5R)-(((4S)-azepan-4-ylamino)carbonyl)-7-oxo-2,6-diazabicyclo(3.2.0)heptane-6-sulfonic acid (Supplementary Concept)
MK 8712 (Supplementary Concept)
relebactam (Supplementary Concept)
3-carboxyphenyl phenylacetamidomethylphosphonate (Supplementary Concept)
durlobactam (Supplementary Concept)
vaborbactam (Supplementary Concept)
ZINC03787097 (Supplementary Concept)
8-oxo-7-(2-oxo-2H-chromene-3-carboxamido)-3-((4-(2-oxo-2H-chromene-3-carboxamido)-phenylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (Supplementary Concept)
3-hydroxy-2-methyl-4H-pyran-4-thione (Supplementary Concept)
6-((biotinyl-N-epsilon-aminocaproyl-N-cystamine-N'-carbonyl)methylsulfonyl)aminopenicillanic acid S,S-dioxide (Supplementary Concept)
6-(biotinyl-N-epsilon-aminocaproyl-N-cystamine-N'-glutaryl)aminopenicillanic acid (Supplementary Concept)
2-((4-pyridiniummethyl)-1,2,3-triazol-1-yl)methyl-6,6-dihydropenicillanate 1,1-dioxide (Supplementary Concept)
2,2-dimethylpenam sulfone (Supplementary Concept)
3-(2'-benzyl-3'-mercaptopropanoyl)-4-carboxy-5, 5-dimethylthiazolidine (Supplementary Concept)
thiomandelic acid (Supplementary Concept)
6,6-bis(hydroxylmethyl)penicillanate (Supplementary Concept)
4-(3-amido-4-phenyl-2-azetidinonyl)-1-phenylacetic acid (Supplementary Concept)
4-(3-amido-4-phenyl-2-azetidinonyl)-1-acetophenone (Supplementary Concept)
LN 1-255 (Supplementary Concept)
BLI-489 (Supplementary Concept)
QPX7728 (Supplementary Concept)
9-O-methylclavulanate (Supplementary Concept)
9-N-isobutylaminodeoxyclavulanate (Supplementary Concept)
Ro 48-1220 (Supplementary Concept)
SYN 1012 (Supplementary Concept)
avibactam (Supplementary Concept)
AVE 1330A (Supplementary Concept)
N-(2'-mercaptoethyl)-2-phenylacetamide (Supplementary Concept)
benzo(b)thiophene-2-boronic acid (Supplementary Concept)
Ro 48-5545 (Supplementary Concept)
Ro 48-8724 (Supplementary Concept)
CH 1240 (Supplementary Concept)
CH 2140 (Supplementary Concept)
SK and F 96464 (Supplementary Concept)
4-(3-amino-2-oxoazetidinonyl-1)methylcyclohexanecarboxylic acid (Supplementary Concept)
4-(3-amino-2-oxoazetidinonyl-1)methylbenzoic acid (Supplementary Concept)
zileuton (Supplementary Concept)
3-(5-hydroxy-4,6,7-trimethyl-1,3-benzoxathiazol-2-yl)propanol (Supplementary Concept)
nafazatrom (Supplementary Concept)
azelastine (Supplementary Concept)
L 670630 (Supplementary Concept)
N-linoleoyldopamine (Supplementary Concept)
piriprost (Supplementary Concept)
1-phenylperhydro-1,2,4-triazin-3-one (Supplementary Concept)
L 708780 (Supplementary Concept)
2',5'-dimethoxy-3,4-dihydroxychalcone (Supplementary Concept)
N-hydroxy-N-(1-(2-phenyl-5-benzofuranyl)ethyl)furancarboxamide (Supplementary Concept)
5-(N-hydroxy-N-(1-(2-(3,4,5-trimethoxyphenyl)-5-benzofuranyl)ethyl)amino)-5-oxopentanoate (Supplementary Concept)
N-hydroxy-N-(1-(2-phenylbenzofuran-5-yl)ethyl)urea (Supplementary Concept)
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid (Supplementary Concept)
chebulagic acid (Supplementary Concept)
2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (Supplementary Concept)
CMI 392 (Supplementary Concept)
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (Supplementary Concept)
4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one (Supplementary Concept)
Wy 45911 (Supplementary Concept)
4-(2-oxapentadeca-4-yne)phenylpropanoic acid (Supplementary Concept)
N-4-(4-methoxyphenylaminosulfonyl)benzoisoselenothiazolidone (Supplementary Concept)
N-4-(4-fluorophenylaminosulfonyl)benzoisoselenothiazolidone (Supplementary Concept)
4-(5-fluoro-3-(4-(2-methyl-1H-imidazol-1-yl)benzyloxy)phenyl)-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide (Supplementary Concept)
N-(3-phenoxycinnamyl)acetohydroxamic acid (Supplementary Concept)
MK-886 (Supplementary Concept)
LY 178002 (Supplementary Concept)
oxphaman (Supplementary Concept)
camelliaside C (Supplementary Concept)
atreleuton (Supplementary Concept)
ocobullenone (Supplementary Concept)
3-oxo-tirucall-8,24-dien-21-oic acid (Supplementary Concept)
1,6-dimethyl-2-(4'-N-n-propylsuccinamido)methyl-3-hydroxypyridin-4(1H)-one (Supplementary Concept)
5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate (Supplementary Concept)
9-hydroperoxy-11,12-octadecadienoic acid (Supplementary Concept)
alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol (Supplementary Concept)
5-Loxin (Supplementary Concept)
12-labdene-15,16,(8)17-trial (Supplementary Concept)
S 29606 (Supplementary Concept)
S 30621 (Supplementary Concept)
2-(4-hydroxyphenyl)-3-(3,5-dihydroxyphenyl)propenoic acid (Supplementary Concept)
2-(4-aminophenyl)-3-(3,5-dihydroxylphenyl)propenoic acid (Supplementary Concept)
4-(5-fluoro-3-(4-(2-methyl-1H-imidazol-1-yl)benzyloxy)phenyl)-4-methoxy-3,4,5,6-tetrahydro-2H-pyran (Supplementary Concept)
tetrapetalone B (Supplementary Concept)
tetrapetalone C (Supplementary Concept)
tetrapetalone D (Supplementary Concept)
S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid (Supplementary Concept)
N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide (Supplementary Concept)
benoxaprofen (Supplementary Concept)
toloxatone (Supplementary Concept)
desmethylselegiline (Supplementary Concept)
Ro 41-1049 (Supplementary Concept)
brofaromine (Supplementary Concept)
milacemide (Supplementary Concept)
tribulin (Supplementary Concept)
rasagiline (Supplementary Concept)
2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (Supplementary Concept)
5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol (Supplementary Concept)
M32 compound (Supplementary Concept)
cimoxatone (Supplementary Concept)
amiflamine (Supplementary Concept)
2-fluoro-2-phenylcyclopropylamine (Supplementary Concept)
lazabemide (Supplementary Concept)
RS 8359 (Supplementary Concept)
pirlindole (Supplementary Concept)
3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one (Supplementary Concept)
amezinium (Supplementary Concept)
1-(beta-D-arabinofuranosyl)-5-ethyluracil (Supplementary Concept)
1-O-(6'-sulfo-alpha-D-glucopyranosyl)-2,3-di-O-phytanyl-sn-glycerol (Supplementary Concept)
N(2)-(4-n-butylphenyl)-2'--deoxyguanosine 5'-imidotriphosphate (Supplementary Concept)
arabinofuranosyl-E-5-iodovinyluracil (Supplementary Concept)
1-beta-arabinofuranosyl-5-ethyluracil 5'-triphosphate (Supplementary Concept)
1-beta-arabinofuranosyl-5-propyluracil-5'-triphosphate (Supplementary Concept)
1-beta-arabinofuranosyl-5-butyluracil-5'-triphosphate (Supplementary Concept)
DAAP1 (Supplementary Concept)
lucidenic acid O (Supplementary Concept)
lucidenic lactone (Supplementary Concept)
polycitone A (Supplementary Concept)
sculezonone A (Supplementary Concept)
sculezonone B (Supplementary Concept)
1-deoxyrubralactone (Supplementary Concept)
9-beta-D-arabinofuranosylguanosine 5'-triphosphate (Supplementary Concept)
fialuridine (Supplementary Concept)
3,4-di-O-galloyl-5-O-digalloylquinic acid (Supplementary Concept)
carbonyldiphosphonate (Supplementary Concept)
G(8-5m)T (Supplementary Concept)
ganciclovir triphosphate (Supplementary Concept)
penciclovir triphosphate (Supplementary Concept)
2,6-diaminopurine (Supplementary Concept)
5-(2-bromoethyl)-2'-deoxyuridine (Supplementary Concept)
5-(2-chloroethyl)-2'-deoxyuridine (Supplementary Concept)
4-n-butylanilino dATP (Supplementary Concept)
5-(2-bromovinyl)uridine (Supplementary Concept)
2',3'-dideoxyguanosine (Supplementary Concept)
Ibezapolstat (Supplementary Concept)
Sch 725680 (Supplementary Concept)
2-hexaprenylhydroquinone (Supplementary Concept)
digallic acid (Supplementary Concept)
5-((1-(2-bromobenzoyl)-5-chloro-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (Supplementary Concept)
ITBA-16 (Supplementary Concept)
emtricitabine tenofovir alafenamide (Supplementary Concept)
TSAO-T (Supplementary Concept)
2'3'-didehydro-2'3'-dideoxyadenosine (Supplementary Concept)
L-697661 (Supplementary Concept)
atevirdine (Supplementary Concept)
3'-azido-2',3'-dideoxy-5-iodouridine (Supplementary Concept)
lamivudine, zidovudine drug combination (Supplementary Concept)
adefovir (Supplementary Concept)
3'-azido-3'-deoxyarabinothymidine (Supplementary Concept)
oltipraz (Supplementary Concept)
6-(1-(2,6-difluorophenyl)ethyl)-2-(dimethylamino)-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
3'-deoxycytidine (Supplementary Concept)
3'-fluoro-2',3'-dideoxyguanosine (Supplementary Concept)
1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine (Supplementary Concept)
loviride (Supplementary Concept)
emivirine (Supplementary Concept)
beta-lapachone (Supplementary Concept)
dexelvucitabine (Supplementary Concept)
2-cyclopentylthio-6-(1-(2,6-difluorophenyl)ethyl)-3,4-dihydro-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
capravirine (Supplementary Concept)
etravirine (Supplementary Concept)
ammonium trichloro(dioxoethylene-O,O'-)tellurate (Supplementary Concept)
3'-azido-2',3'-dideoxy-5-methylcytidine (Supplementary Concept)
ulonivirine (Supplementary Concept)
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
stavudine, lamivudine, nevirapine drug combination (Supplementary Concept)
GS-9131 (Supplementary Concept)
abacavir (Supplementary Concept)
adefovir dipivoxil (Supplementary Concept)
R-82913 (Supplementary Concept)
XZ460 (Supplementary Concept)
XZ456 (Supplementary Concept)
XZ462 (Supplementary Concept)
5-hexyne-1,4-diamine (Supplementary Concept)
3-(aminooxy)-2-fluoropropanamine (Supplementary Concept)
alpha-monofluoromethylputrescine (Supplementary Concept)
2-amino-5-iodoacetamidopentanoic acid (Supplementary Concept)
N(1),N(4)-bis(benzyl)-N(1),N(4)-bis(methyl)putrescine (Supplementary Concept)
alpha-difluoromethylputrescine (Supplementary Concept)
alpha-(fluoromethyl)dehydroornithine (Supplementary Concept)
alpha-(fluoromethyl)dehydroputrescine (Supplementary Concept)
6-heptyne-2,5-diamine (Supplementary Concept)
5,6-heptadiene-1,4-diamine (Supplementary Concept)
phenyl-(2-difluoroethyl)-4-aminopropylamidinohydrazone (Supplementary Concept)
delta-N-hydroxyornithine (Supplementary Concept)
ribosomal protein S20-L26 (Supplementary Concept)
1-aminooxy-4-aminobutane (Supplementary Concept)
2-(fluoromethyl)dehydroornithine ethyl ester (Supplementary Concept)
5,8-dimethylspermidine (Supplementary Concept)
alpha-hydrazinoornithine (Supplementary Concept)
1-aminooxy-3-aminopropane (Supplementary Concept)
2-(fluoromethyl)dehydroornithine methyl ester (Supplementary Concept)
methylglyoxal bis(3-aminopropylamidinohydrazone) (Supplementary Concept)
2,2-difluoro-5-hexyne-1,4-diamine (Supplementary Concept)
doxantrazole (Supplementary Concept)
zaprinast (Supplementary Concept)
phthalazinol (Supplementary Concept)
cilostamide (Supplementary Concept)
EMD 53998 (Supplementary Concept)
E 4021 (Supplementary Concept)
toborinone (Supplementary Concept)
ibudilast (Supplementary Concept)
piroximone (Supplementary Concept)
2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (Supplementary Concept)
pimobendan (Supplementary Concept)
vesnarinone (Supplementary Concept)
imazodan (Supplementary Concept)
4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone (Supplementary Concept)
edelfosine (Supplementary Concept)
sulmazole (Supplementary Concept)
doxofylline (Supplementary Concept)
lipomodulin (Supplementary Concept)
prostaglandin Bx (Supplementary Concept)
siguazodan (Supplementary Concept)
denbufylline (Supplementary Concept)
manoalide (Supplementary Concept)
UD CG 212 Cl (Supplementary Concept)
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (Supplementary Concept)
(S)-6-((1-(4-chlorophenyl)ethyl)amino)-1-cyclopentyl-1,5,6,7-tetrahydro-4H-pyrazolo(3,4-day)pyrimidin-4-one (Supplementary Concept)
PDM-631 (Supplementary Concept)
BC54 compound (Supplementary Concept)
vinpocetine (Supplementary Concept)
tricyclodecane-9-yl-xanthogenate (Supplementary Concept)
1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one (Supplementary Concept)
diniprofylline (Supplementary Concept)
BI 409306 (Supplementary Concept)
T 2585 (Supplementary Concept)
zardaverine (Supplementary Concept)
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one (Supplementary Concept)
dodecylphosphocholine (Supplementary Concept)
olprinone (Supplementary Concept)
piclamilast (Supplementary Concept)
apremilast (Supplementary Concept)
KW 4490 (Supplementary Concept)
MK 0873 (Supplementary Concept)
1-(4-(difluoromethoxy)-3-((tetrahydrofuran-3-yl)oxy)phenyl)-3-methylbutan-1-one (Supplementary Concept)
roflupram (Supplementary Concept)
CI 1044 (Supplementary Concept)
Cilomilast (Supplementary Concept)
CC-11050 (Supplementary Concept)
BPN14770 (Supplementary Concept)
4-cyano-4-(2,3-dihydro-8-methoxy-1,4-benzodioxin-5-yl)cyclohexanecarboxylic acid (Supplementary Concept)
roflumilast N-oxide (Supplementary Concept)
Zl-n-91 compound (Supplementary Concept)
6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide (Supplementary Concept)
Hemay005 (Supplementary Concept)
T 1032 (Supplementary Concept)
mirodenafil (Supplementary Concept)
udenafil (Supplementary Concept)
aildenafil (Supplementary Concept)
N-(6-aminohexyl)-3-(1-ethyl-3-methyl-7-oxo-6,7-dihydro-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-propoxybenzenesulfonamide (Supplementary Concept)
3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one (Supplementary Concept)
methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (Supplementary Concept)
tenalisib (Supplementary Concept)
inavolisib (Supplementary Concept)
pachymic acid (Supplementary Concept)
darapladib (Supplementary Concept)
methyl 6-methoxy-2-phenethylquinoline-4-carboxylate (Supplementary Concept)
1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-5-carbonitrile (Supplementary Concept)
PF-5212372 (Supplementary Concept)
IS 741 (Supplementary Concept)
pyrrophenone (Supplementary Concept)
AX 059 (Supplementary Concept)
AX 115 (Supplementary Concept)
FKGK2 compound (Supplementary Concept)
ecopladib (Supplementary Concept)
varespladib methyl (Supplementary Concept)
letermovir (Supplementary Concept)
6-nitroso-1,2-benzopyrone (Supplementary Concept)
4-amino-1,8-naphthalimide (Supplementary Concept)
iniparib (Supplementary Concept)
3-methoxybenzamide (Supplementary Concept)
3-aminobenzamide (Supplementary Concept)
3-nitrosobenzamide (Supplementary Concept)
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone (Supplementary Concept)
phenanthridone (Supplementary Concept)
pamiparib (Supplementary Concept)
GPI 15427 (Supplementary Concept)
2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one (Supplementary Concept)
KU0058948 (Supplementary Concept)
rucaparib (Supplementary Concept)
olaparib (Supplementary Concept)
4-(3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl)-2H-phthalazin-1-one (Supplementary Concept)
thieno(2,3-c)isoquinolin-5-one (Supplementary Concept)
3,4-dihydro-5-hydroxy-1(2H)-isoquinolinone (Supplementary Concept)
2-(4-cyclopropylmethylpiperazin-1-yl)-5H-benzo(c)(1,5)naphthyridin-6-one (Supplementary Concept)
10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one (Supplementary Concept)
1,5-dihydroxyisoquinoline (Supplementary Concept)
2-(4-hydroxyphenyl)-1H-benzimidazole-4-carboxamide (Supplementary Concept)
1,5-dihydroisoquinoline (Supplementary Concept)
fluzoparib (Supplementary Concept)
2-(methoxycarbonyl(4-methoxyphenyl)methylsulfanyl)-1H-benzimidazole-4-carboxylic acid amide (Supplementary Concept)
PARP-1 inhibitor DHC-1 (Supplementary Concept)
veliparib (Supplementary Concept)
cofpropamine (Supplementary Concept)
2-(4-(pyridin-2-yl)phenyl)-1H-benzo(d)imidazole-4-carboxamide (Supplementary Concept)
niraparib (Supplementary Concept)
2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (Supplementary Concept)
2-(4-chlorophenyl)-5-quinoxalinecarboxamide (Supplementary Concept)
6-amino-1,2-benzopyrone (Supplementary Concept)
talazoparib (Supplementary Concept)
ME0328 (Supplementary Concept)
N-(bis(4-methoxyphenyl)methyl)-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (Supplementary Concept)
2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside (Supplementary Concept)
4-aminomethylbenzoic acid (Supplementary Concept)
alpha-1-microglobulin (Supplementary Concept)
amastatin (Supplementary Concept)
globomycin (Supplementary Concept)
alpha 1-inhibitor 3 (Supplementary Concept)
4-toluenesulfonyl fluoride (Supplementary Concept)
remikiren (Supplementary Concept)
camostat (Supplementary Concept)
3-amino-2-hydroxy-4-phenylbutanoic acid (Supplementary Concept)
BB 1101 (Supplementary Concept)
TIMP3 protein, human (Supplementary Concept)
carbobenzoxy-leucyl-leucyl-norvalinal (Supplementary Concept)
pigment epithelium-derived factor (Supplementary Concept)
sampatrilat (Supplementary Concept)
N-acetyltryptophan (Supplementary Concept)
1,6-bis(cyclohexyloximinocarbonyl)hexane (Supplementary Concept)
ovomacroglobulin (Supplementary Concept)
NCO 650 (Supplementary Concept)
antistasin (Supplementary Concept)
nafamostat (Supplementary Concept)
GC376 (Supplementary Concept)
valyl-(aspartyl)4-lysyl-chloromethane (Supplementary Concept)
N-carboxy-3-phenylpropyl-alanyl-aminoisobutyric acid-tyrosyl-aminobenzoate (Supplementary Concept)
2-mercaptomethyl-3-guanidinoethylthiopropionic acid (Supplementary Concept)
4-hydroxymercuribenzoate (Supplementary Concept)
pepstatin (Supplementary Concept)
proteinase inhibitor I (plants) (Supplementary Concept)
Sch 34826 (Supplementary Concept)
enalkiren (Supplementary Concept)
murinoglobulin (Supplementary Concept)
TIMP1 protein, human (Supplementary Concept)
TIMP2 protein, human (Supplementary Concept)
Timp1 protein, mouse (Supplementary Concept)
Sch 39370 (Supplementary Concept)
candoxatrilat (Supplementary Concept)
ecabet (Supplementary Concept)
SCH 32615 (Supplementary Concept)
epicatechin gallate (Supplementary Concept)
candoxatril (Supplementary Concept)
batimastat (Supplementary Concept)
asunaprevir (Supplementary Concept)
benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene (Supplementary Concept)
1,2-epoxy-3-(p-nitrophenoxy)propane (Supplementary Concept)
phosphoramidon (Supplementary Concept)
UK-383,367 (Supplementary Concept)
sepimostate mesilate (Supplementary Concept)
racecadotril (Supplementary Concept)
ditekiren (Supplementary Concept)
TMC-310911 (Supplementary Concept)
renin inhibitory peptide (Supplementary Concept)
ubenimex (Supplementary Concept)
LVV-hemorphin 6 (Supplementary Concept)
imidapril (Supplementary Concept)
N-((1-((2-(acetylthio)-3-methyl-1-oxobutyl)amino)-1-cyclopentyl)carbonyl)-O-methyl-L-tyrosine ethyl ester (Supplementary Concept)
N-(1-carboxy-3-phenylpropyl)-alanylalanine (Supplementary Concept)
imidaprilat (Supplementary Concept)
trandolapril (Supplementary Concept)
benazeprilat (Supplementary Concept)
libenzapril (Supplementary Concept)
ramiprilat (Supplementary Concept)
spirapril (Supplementary Concept)
perindoprilat (Supplementary Concept)
rentiapril (Supplementary Concept)
L-proline, N2-((1S)-1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl- (Supplementary Concept)
N-(2-(mercaptomethyl)-3-methylbutanoyl)-4-(1H-pyrazol-1-yl)phenylalanine (Supplementary Concept)
7-((2-(acetylthio)-1-oxo-3-methylpropyl)amino)-1,2,3,4,6,7,8,12b-octahydro-6-oxopyrido(2,1-a)(2)benzazepin-4-carboxyacid (Supplementary Concept)
temocapril hydrochloride (Supplementary Concept)
benazepril (Supplementary Concept)
zofenopril (Supplementary Concept)
captopril, hydrochlorothiazide drug combination (Supplementary Concept)
cilazaprilat (Supplementary Concept)
(S)-malic acid 1'-O-beta-gentiobioside (Supplementary Concept)
alacepril (Supplementary Concept)
fosinoprilat (Supplementary Concept)
delapril (Supplementary Concept)
quinaprilat (Supplementary Concept)
ceronapril (Supplementary Concept)
moexipril (Supplementary Concept)
IRW peptide (Supplementary Concept)
valyl-prolyl-proline (Supplementary Concept)
2-(2-(5-bromoindan-1-yl)-3-mercaptopropionylamino)-3-(1H-pyrrolo(2,3-b)pyridin-3-yl)propionic acid (Supplementary Concept)
glyceraldehyde 3-phosphate dehydrogenase (304-313) (Supplementary Concept)
MDL 100240 (Supplementary Concept)
gemopatrilat (Supplementary Concept)
acetylleucyl-leucyl-norleucinal (Supplementary Concept)
calpain inhibitor 2 (Supplementary Concept)
calpeptin (Supplementary Concept)
benzyloxycarbonylleucyl-leucyl-leucine aldehyde (Supplementary Concept)
cystatin, egg-white (Supplementary Concept)
nitroaspirin (Supplementary Concept)
inhibitor of apoptosis, Nucleopolyhedrovirus (Supplementary Concept)
benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal (Supplementary Concept)
benzyloxycarbonylphenylalanylalanine diazomethyl ketone (Supplementary Concept)
E 64 (Supplementary Concept)
aloxistatin (Supplementary Concept)
aspartyl-glutamyl-valyl-aspartal (Supplementary Concept)
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone (Supplementary Concept)
Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin (Supplementary Concept)
calpain inhibitors (Supplementary Concept)
leupeptin (Supplementary Concept)
calpastatin (Supplementary Concept)
phenylalanyl-prolyl-arginine-chloromethyl ketone (Supplementary Concept)
succinyl-alanyl-valyl-valyl-alanyl-psi(CH2NH)-alanyl-4-nitroanilide (Supplementary Concept)
succinyl-alanyl-valyl-valyl-psi(CH2NH)-alanyl-alanyl-4-nitroanilide (Supplementary Concept)
SF 324 (Supplementary Concept)
pentenocin A (Supplementary Concept)
pentenocin B (Supplementary Concept)
benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone (Supplementary Concept)
1,3-bis(acylamino)-2-butanone (Supplementary Concept)
L 709049 (Supplementary Concept)
N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone (Supplementary Concept)
clasto-lactacystin beta-lactone (Supplementary Concept)
acetyl-aspartyl-glutamyl-valyl-aspartal (Supplementary Concept)
MDL 201053 (Supplementary Concept)
calpain inhibitor III (Supplementary Concept)
BIRC5 protein, human (Supplementary Concept)
lactacystin (Supplementary Concept)
N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline (Supplementary Concept)
4-hydroxy-2-nonenal (Supplementary Concept)
NOL3 protein, human (Supplementary Concept)
benzyloxycarbonyl aspartyl-glutamyl-valyl-aspartyl-chloromethyl ketone (Supplementary Concept)
PD 194035 (Supplementary Concept)
N1445 (Supplementary Concept)
benzyloxycarbonyl-aspartyl(O-methyl)fluoromethane (Supplementary Concept)
VRT 018858 (Supplementary Concept)
4-(ethoxycarbonylmethoxy)-1-hydroxy-2-naphthoic acid (Supplementary Concept)
benzyloxycarbonyl-tert-leucyl-aspartic acid (Supplementary Concept)
z-Val-Ala-Asp(Ome)-fluoromethylketone (Supplementary Concept)
EI 2128-1 (Supplementary Concept)
CM 269 (Supplementary Concept)
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone (Supplementary Concept)
CV 1013 (Supplementary Concept)
Xyz 033 mp (Supplementary Concept)
acetyl-leucyl-glutamyl-histidyl-aspartal (Supplementary Concept)
Z-Asp-2,6-dichlorobenzoyl-oxymethylketone (Supplementary Concept)
Ac-AAVALLPAVLLALLAPYVAD-CHO (Supplementary Concept)
benzyloxycarbonyl-valyl-alanyl-(methyl)aspartic acid fluoromethyl ketone (Supplementary Concept)
acetyl-AAVALLPAVLLALLAP-DEVD-CHO (Supplementary Concept)
acetyl-aspartyl-glutamyl-valyl-lysine chloromethyl ketone (Supplementary Concept)
BIRC8 protein, human (Supplementary Concept)
1-(4-(2-fluoroethoxy)benzyl)-5-(1-(2-methoxymethylpyrrolidinyl)sulfonyl)isatin (Supplementary Concept)
butyloxycarbonyl-O-methyl-aspartyl-fluoromethyl ketone (Supplementary Concept)
tyrosyl-valyl-alanyl-aspartal (Supplementary Concept)
IDN 1529 (Supplementary Concept)
N-((1,3-dimethylindole-2-carbonyl)-valinyl)-3-amino-4-oxo-5-fluoropentanoic acid (Supplementary Concept)
TMC 2B (Supplementary Concept)
TMC 2C (Supplementary Concept)
diprotin A (Supplementary Concept)
N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine (Supplementary Concept)
saxagliptin (Supplementary Concept)
1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine (Supplementary Concept)
4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine (Supplementary Concept)
4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine (Supplementary Concept)
1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile (Supplementary Concept)
lipoyl vildagliptin (Supplementary Concept)
5-hydroxysaxagliptin (Supplementary Concept)
anagliptin (Supplementary Concept)
1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile (Supplementary Concept)
3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide (Supplementary Concept)
sulphostin (Supplementary Concept)
1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile (Supplementary Concept)
3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide (Supplementary Concept)
(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone (Supplementary Concept)
ABT 341 (Supplementary Concept)
4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one (Supplementary Concept)
alogliptin (Supplementary Concept)
3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one (Supplementary Concept)
NN 7201 (Supplementary Concept)
methionyl-2-cyanopyrrolidine (Supplementary Concept)
1-(2-(5-cyano-2-pyridinylamino)ethylamino)acetyl-2-pyrrolidinecarbonitrile (Supplementary Concept)
1-(4-aminomethyl-4-(3-chlorophenyl)cyclohexyl)-tetrahydropyrimidin-2-one (Supplementary Concept)
Syrrx 106124 (Supplementary Concept)
N-(2-isobutyl-3-(N'-hydroxycarbonylamido)propanoyl)-O-methyltyrosinemethylamide (Supplementary Concept)
BB87 collagenase inhibitor (Supplementary Concept)
N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide (Supplementary Concept)
matlystatin A (Supplementary Concept)
matlystatin B (Supplementary Concept)
matlystatin D (Supplementary Concept)
matlystatin E (Supplementary Concept)
matlystatin F (Supplementary Concept)
prinomastat (Supplementary Concept)
4-des-dimethylaminotetracycline (Supplementary Concept)
CL82198 (Supplementary Concept)
S 3304 (Supplementary Concept)
SM 7368 (Supplementary Concept)
N-hydroxy-4-((4-(phenylthio)phenyl)sulfonyl)-1-(2-propynyl)-4-piperidinecarboxamide (Supplementary Concept)
5-aza-6-cyclohexylmethyl-3-cyclohexylpropyl-4,7-dioxo-7-(phenylethylamino)heptanohydroxamic acid (Supplementary Concept)
5-aza-6-cyclohexylmethyl-4,7-dioxo-7-(phenylethylamino)-3-phenylpropylheptanohydroxamic acid (Supplementary Concept)
PD 180557 (Supplementary Concept)
(R)-2-(4'-bromo-biphenyl-4-sulfonyl-amino)-3-methyl-butyric acid (Supplementary Concept)
N-biphenylsulfonylphenylalanine hydroxamic acid (Supplementary Concept)
N-hydroxy-4-((4-methoxyphenyl)sulfonyl)-2,2-dimethylhexahydro-1,4-thiazepine-3-carboxamide (Supplementary Concept)
N-hydroxy-4-((4--methoxyphenyl)sulfonyl)-2,2-dimethylhexahydro-1,4-thiazepine-3-carboxamide 1,1-dioxide (Supplementary Concept)
funalenone (Supplementary Concept)
PGE 1132881 (Supplementary Concept)
Ro 26-2812 (Supplementary Concept)
MAG 283 (Supplementary Concept)
YLL 224 (Supplementary Concept)
dichloro(diethyl((methylsulfinyl)methyl)phosphonate)platinum(II) (Supplementary Concept)
(diethyl((methylsulfinyl)methyl)phosphonate)(dimethylmalonato)platinum(II) (Supplementary Concept)
2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone (Supplementary Concept)
RXP 409 (Supplementary Concept)
triazin 17-2 (Supplementary Concept)
5-methyl-2-(4-methylphenyl)-1H-benzimidazole (Supplementary Concept)
4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide (Supplementary Concept)
N-hydroxy-2-(4-methoxybenzenesulfonyl)-2-methyl-3-(4-(2-piperidin-1-ylethoxy)phenyl)propionamide (Supplementary Concept)
1-benzyl-4-(4-(4-chlorophenoxy)benzenesulfonyl)piperidine-4-carboxylic acid (Supplementary Concept)
2-(4-hydroxy-3-methyl-2-butenyl)hydroquinone (Supplementary Concept)
3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid (Supplementary Concept)
2-((4-biphenylsulfonyl)amino)-3-phenylpropionic acid (Supplementary Concept)
N-hydroxy-4-((4-(4-(trifluoromethyl)phenoxy)phenyl)sulfonyl)tetrahydro-2H-pyran-4-carboxamide (Supplementary Concept)
N-hydroxy-1-(2-methoxyethyl)-4-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)piperidine-4-carboxamide (Supplementary Concept)
1-cyclopropyl-N-hydroxy-4-(4-(4-(trifluoromethoxy)phenoxy)phenylsulfonyl)piperidine-4-carboxamide (Supplementary Concept)
PF152 compound (Supplementary Concept)
RXP470.1 peptide (Supplementary Concept)
3-methyl-2-(4-(3-p-tolyl(1,2,4)oxadiazol-5-yl)benzenesulfonylamino)butyric acid (Supplementary Concept)
saucerneol G (Supplementary Concept)
4-methyl-1-((5-((3-oxo-3,4-dihydro-2H-benzo(1,4)oxazin-6-ylmethyl)carbamoyl)pyrazolo(1,5-a)pyrimidine-7-carbonyl)amino)indan-5-carboxylic acid (Supplementary Concept)
cadin-2-en-1-ol-1-glucuronopyranoside (Supplementary Concept)
YL 01869P (Supplementary Concept)
N2-(2-((hydroxycarbamoyl)methyl)-4-methylvaleryl)-N1,3-dimethylvalinamide (Supplementary Concept)
N-(3-N-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-O-methyltyrosine N-methylamide (Supplementary Concept)
N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide (Supplementary Concept)
2-(biphenyl-4-ylsulfonyl)-1,2,3,4-tetrahydroisoquinolin-3-carboxylic acid (Supplementary Concept)
N-hydroxy-5-ethoxymethyloxy-2-methyl-4-(4-phenoxybenzoyl)aminopentanamide (Supplementary Concept)
OSU8 1 (Supplementary Concept)
N-alpha-(4-(2-phenyl-2H- tetrazole-5-yl) phenyl sulfonyl)-D-tryptophan (Supplementary Concept)
SI 27 (Supplementary Concept)
CH1766 (Supplementary Concept)
CH6631 (Supplementary Concept)
N(4)-(2,2-dimethyl-1-methylcarbamoylpropyl)-N(1)-hydroxy-2-hydroxymethyl-3-(4-methoxyphenyl)succinamide (Supplementary Concept)
N(4)-(2,2-dimethyl-1-methylcarbamoylpropyl)-N(1)-hydroxy-2-hydroxymethyl-3-phenylsuccinamide (Supplementary Concept)
zincov (Supplementary Concept)
N-benzyloxycarbonyl-prolyl-alanyl-3-amino-2-oxopropyl-leucyl-alanyl-glycine ethyl ester (Supplementary Concept)
AZD3342 (Supplementary Concept)
3,4,5-trihydroxybenzaldehyde (Supplementary Concept)
methyl 6-(benzyloxycarbonylamino)-2-(2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetamido)hexanoate (Supplementary Concept)
2-(8-(methoxycarbonylamino)dibenzo(b,d)furan-3-sulfonamido)-3-methylbutanoic acid (Supplementary Concept)
4-(carboxy-(5-(4'-ethoxyphenyl)thiophene-2-sulfonylamino)methyl)piperidine-1-carboxylic acid isopropyl ester (Supplementary Concept)
LY52 compound (Supplementary Concept)
SCH 43534 (Supplementary Concept)
L 758354 (Supplementary Concept)
Ro 32-3555 (Supplementary Concept)
2-(4-(but-2-ynyloxy)phenylsulfonamido)-3-(1-(4-methoxybenzyl)-1H-indol-3-yl)propanoic acid (Supplementary Concept)
2-(4'-methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid (Supplementary Concept)
N-hydroxy-2-(((4'-methoxyphenyl)sulfonyl)benzylamino)-3-methylbutanamide (Supplementary Concept)
6-(4-(4-imidazol-1-ylphenoxy)benzenesulfonyl)-4,5,6,7-tetrahydrofuro(2,3-c)pyridine-5-carboxylic acid (Supplementary Concept)
CGS 27023 (Supplementary Concept)
PNU 141803 (Supplementary Concept)
PNU 142372 (Supplementary Concept)
PNU 107859 (Supplementary Concept)
CT 1418 (Supplementary Concept)
3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)N-hydroxy-5-methylhexanamide (Supplementary Concept)
phthaloyl-glycyl(P)-isoleucyl-tryptophyl-benzylamide (Supplementary Concept)
epoxomicin (Supplementary Concept)
TIR-199 (Supplementary Concept)
delanzomib (Supplementary Concept)
DPLG3 (Supplementary Concept)
PR-957 (Supplementary Concept)
aliskiren (Supplementary Concept)
subtilisin inhibitor protein, Streptomyces (Supplementary Concept)
tick anticoagulant peptide (Supplementary Concept)
tissue-factor-pathway inhibitor 2 (Supplementary Concept)
sivelestat (Supplementary Concept)
ICI 200355 (Supplementary Concept)
L 658758 (Supplementary Concept)
SERPIN-B5 (Supplementary Concept)
(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid (Supplementary Concept)
ITIH4 protein, human (Supplementary Concept)
4-(2-aminoethyl)benzenesulfonylfluoride (Supplementary Concept)
chymostatin (Supplementary Concept)
SPINT2 protein, human (Supplementary Concept)
4-aminobenzamidine (Supplementary Concept)
Eco protein, E coli (Supplementary Concept)
lipoprotein-associated coagulation inhibitor (Supplementary Concept)
benzamidine (Supplementary Concept)
berotralstat (Supplementary Concept)
methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone (Supplementary Concept)
SPINK7 protein, human (Supplementary Concept)
chymotrypsin inhibitor 2 (Supplementary Concept)
cholesteryl sulfate (Supplementary Concept)
DAPI (Supplementary Concept)
3,4-dichloroisocoumarin (Supplementary Concept)
4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate (Supplementary Concept)
MDSPI16 (Supplementary Concept)
ecotin protein, Yersinia pestis (Supplementary Concept)
ecotin protein, Pseudomonas aeruginosa (Supplementary Concept)
eglin proteinase inhibitors (Supplementary Concept)
kempopeptin C (Supplementary Concept)
inter-alpha-inhibitor (Supplementary Concept)
bivalirudin (Supplementary Concept)
melagatran (Supplementary Concept)
argatroban (Supplementary Concept)
lepirudin (Supplementary Concept)
SDZ MTH 958 (Supplementary Concept)
inogatran (Supplementary Concept)
ximelagatran (Supplementary Concept)
6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one hydrochloride (Supplementary Concept)
HY023016 (Supplementary Concept)
ITF 1331 (Supplementary Concept)
SEL 2711 (Supplementary Concept)
YM 60828 (Supplementary Concept)
FX 2212 (Supplementary Concept)
PD0313052 (Supplementary Concept)
WX-FX4 compound (Supplementary Concept)
6-chloromethyl-3-(2,5-dichlorophenoxycarbonyl)-2-benzopyrone (Supplementary Concept)
3,3'-(3,5-difluoro-4-methyl-2,6-pyridinediylbis(oxy))bis(benzenecarbox(imide)amide) (Supplementary Concept)
RPR 130737 (Supplementary Concept)
BnSO(2)-D-Arg-Gly-Arg-ketothiazole (Supplementary Concept)
lefaxin (Supplementary Concept)
N(2)-(4-(dimethylamino)benzoyl)-4-hydroxy-N(1)-(4-methoxybenzoyl)-1,2-benzenediamine (Supplementary Concept)
2-(4-(dimethylamino)benzoylamino)-5-methanesulfonylamino-N'-(4-methoxyphenyl)benzamide (Supplementary Concept)
RPR 208566 (Supplementary Concept)
N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide (Supplementary Concept)
3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-((methylamino)methyl)-2-thiophenecarboxamide (Supplementary Concept)
3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-(((4,5-dihydro-2-oxazolyl)methylamino)methyl)-2-thiophenecarboxamide (Supplementary Concept)
2-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)propanoyl)piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo(1,5-c)imidazol-3-one (Supplementary Concept)
2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide (Supplementary Concept)
ZK 806299 (Supplementary Concept)
DPC 602 (Supplementary Concept)
RPR 209685 (Supplementary Concept)
1-(1-amino-7-isoquinolyl)-N-(2'-(aminosulfonyl)-1,1'-biphenyl-4-yl)-3-methyl-1H-pyrazole-5-carboxamide (Supplementary Concept)
idraparinux (Supplementary Concept)
edoxaban (Supplementary Concept)
1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one (Supplementary Concept)
Amblyomin-X protein, Amblyomma cajennense (Supplementary Concept)
darexaban (Supplementary Concept)
factor Xa, Glu-Gly-Arg- (Supplementary Concept)
1-(2,2-difluoroethyl)pyrrolidine-3,4-dicarboxylic acid 3-((5-chloropyridin-2-yl)amide) 4-((2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl)amide) (Supplementary Concept)
SV-66 protein, Simulium vittatum (Supplementary Concept)
lufaxin protein, Lutzomyia longipalpis (Supplementary Concept)
therostasin protein, Theromyzon tessulatum (Supplementary Concept)
3-(4-(5-(2,6-dimethyltetrahydro-1(2H)-pyridinyl)pentyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)-1-benzenecarboximidamide (Supplementary Concept)
SE 170 (Supplementary Concept)
1-(3-(aminomethyl)phenyl)-N-(3-fluoro-2'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (Supplementary Concept)
otamixaban (Supplementary Concept)
alpha-(3-amidinylphenoxy)-2-bromo-N-(5-(pyrrolidin-1-ylcarbonyl)phenyl)phenylacetamide (Supplementary Concept)
4-((2-amidino-1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl)-1-(4-pyridinyl)piperidine-4-carboxylic acid monomethanesulfonate trihydrate (Supplementary Concept)
eisenstasin (Supplementary Concept)
N-(4-(1-(acetimidoyl)piperidin-4-yloxy)-3-carbamoylphenyl)-N-(3-(3-amidinophenyl)-2-fluoro-2-propenyl)sulfamoylacetic acid (Supplementary Concept)
branebrutinib (Supplementary Concept)
GSK2636771 (Supplementary Concept)
1-(3-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-6-(2'-(3-hydroxy-N-pyrrolidinyl)methyl-(1,1')-biphen-4-yl)-1,4,5,6-tetrahydropyrazolo-(3,4-c)-pyridin-7-one (Supplementary Concept)
RWJ 445167 (Supplementary Concept)
apixaban (Supplementary Concept)
betrixaban (Supplementary Concept)
BMS 269223 (Supplementary Concept)
6-(dimethylcarbamoyl)nicotinoyl guanidine (Supplementary Concept)
3-(4-(5-(2,6-dimethylpiperidin-1-yl)pentyl)-3-oxo-3,4-dihydroxyquinoxalin-2-yl)benzamidine (Supplementary Concept)
2-carbamoyl-4-((6-chloronaphthalen-2-yl)sulfonyl)-1-((5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl)carbonyl)piperazine (Supplementary Concept)
ZK 805412 (Supplementary Concept)
RPR 120844 (Supplementary Concept)
isoleucyl-glutamyl-glycyl-arginine chloromethyl ketone (Supplementary Concept)
5-chlorothiophene-2-carboxylic acid (2-(2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino)-3-(4-methylpiperazin-1-yl)-3-oxopropyl)amide (Supplementary Concept)
alirocumab (Supplementary Concept)
evolocumab (Supplementary Concept)
somatomedin B (Supplementary Concept)
urinastatin (Supplementary Concept)
nirmatrelvir (Supplementary Concept)
deldeprevir (Supplementary Concept)
DMP 323 (Supplementary Concept)
kynostatin 272 (Supplementary Concept)
Abbott 77003 (Supplementary Concept)
tetrahydrofuranylcarbamatemonopyrrolinone (Supplementary Concept)
amprenavir (Supplementary Concept)
fosamprenavir (Supplementary Concept)
hinnuliquinone (Supplementary Concept)
N-(2''-hydroxy-2''-(4-hydroxy-16-oxo-7,8,9,10,11,12,13,14,15,16-decahydro-6H-5-oxa-15-azabenzocyclotetradecen-14-yl)ethyl)-N-isobutyl-4-methoxybenzenesulfonamide (Supplementary Concept)
vactosertib (Supplementary Concept)
A-484954 (Supplementary Concept)
entrectinib (Supplementary Concept)
prexasertib (Supplementary Concept)
ravoxertinib (Supplementary Concept)
2-((3-acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (Supplementary Concept)
adenosine-3',5'-cyclic phosphorothioate (Supplementary Concept)
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide (Supplementary Concept)
protein kinase inhibitor peptide (6-24) (Supplementary Concept)
protein kinase inhibitor M (6-24) (Supplementary Concept)
KN 93 (Supplementary Concept)
KT 5823 (Supplementary Concept)
9-phenanthrol (Supplementary Concept)
alvocidib (Supplementary Concept)
PD 166866 (Supplementary Concept)
N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide (Supplementary Concept)
GSK2646264 (Supplementary Concept)
FF-10101 (Supplementary Concept)
AZD0156 (Supplementary Concept)
GS-680 (Supplementary Concept)
LIMKi3 (Supplementary Concept)
RapaLink-1 (Supplementary Concept)
abrocitinib (Supplementary Concept)
selonsertib (Supplementary Concept)
R333 (Supplementary Concept)
tucatinib (Supplementary Concept)
JTE-952 (Supplementary Concept)
GSK3186899 (Supplementary Concept)
chiauranib (Supplementary Concept)
aflutinib (Supplementary Concept)
AZD7648 (Supplementary Concept)
belizatinib (Supplementary Concept)
TAS-121 (Supplementary Concept)
onvansertib (Supplementary Concept)
LN950 (Supplementary Concept)
TAK1 inhibitor NG25 (Supplementary Concept)
AZ5104 (Supplementary Concept)
YKL-5-124 (Supplementary Concept)
YKL-05-099 (Supplementary Concept)
IBL-302 (Supplementary Concept)
lazertinib (Supplementary Concept)
TKM-080301 (Supplementary Concept)
KIRA6 (Supplementary Concept)
bafetinib (Supplementary Concept)
ON 01910 (Supplementary Concept)
CGP 77675 (Supplementary Concept)
vatalanib (Supplementary Concept)
SB 239063 (Supplementary Concept)
PKI 166 (Supplementary Concept)
PD 180970 (Supplementary Concept)
orantinib (Supplementary Concept)
MP 412 (Supplementary Concept)
nintedanib (Supplementary Concept)
lenvatinib (Supplementary Concept)
PF 00477736 (Supplementary Concept)
hesperadin (Supplementary Concept)
7-hydroxystaurosporine (Supplementary Concept)
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (Supplementary Concept)
N-(2-aminoethyl)-5-isoquinolinesulfonamide (Supplementary Concept)
KRP4 protein, Arabidopsis (Supplementary Concept)
N-(4-methyl-3-(1-methyl-7-(6-methylpyridin-3-ylamino)-2-oxo-1,2-dihydropyrimido(4,5-d)pyrimidin-3(4H)-yl)phenyl)-3-(trifluoromethyl)benzamide (Supplementary Concept)
tivozanib (Supplementary Concept)
apatinib (Supplementary Concept)
trametinib (Supplementary Concept)
dabrafenib (Supplementary Concept)
N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide (Supplementary Concept)
calphostin D (Supplementary Concept)
protein kinase inhibitor peptide (Supplementary Concept)
protein kinase inhibitor peptide (1-31) (Supplementary Concept)
CHMFL-FLT3-213 compound (Supplementary Concept)
motesanib diphosphate (Supplementary Concept)
OTS167 (Supplementary Concept)
rimacalib (Supplementary Concept)
4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (Supplementary Concept)
ONO-7579 (Supplementary Concept)
X480 (Supplementary Concept)
voruciclib (Supplementary Concept)
SHC004-221A1 (Supplementary Concept)
PF-5236216 (Supplementary Concept)
Debio 0617B (Supplementary Concept)
1-(5-isoquinolinylsulfonyl)-3-methylpiperazine (Supplementary Concept)
butyrolactone I (Supplementary Concept)
WZ4002 (Supplementary Concept)
XL647 (Supplementary Concept)
agerafenib (Supplementary Concept)
ilorasertib (Supplementary Concept)
AL622 (Supplementary Concept)
spebrutinib (Supplementary Concept)
ipatasertib (Supplementary Concept)
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (Supplementary Concept)
4,5-dianilinophthalimide (Supplementary Concept)
8-((3-bromophenyl)amino)-3-methyl-3H-imidazo(4,5-g)quinazoline (Supplementary Concept)
EKB 569 (Supplementary Concept)
2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide (Supplementary Concept)
midostaurin (Supplementary Concept)
fasudil (Supplementary Concept)
belumosudil (Supplementary Concept)
LS-106 (Supplementary Concept)
PRN473 (Supplementary Concept)
remibrutinib (Supplementary Concept)
TAS-119 (Supplementary Concept)
naporafenib (Supplementary Concept)
LPM4870108 (Supplementary Concept)
LUT014 (Supplementary Concept)
OATD-01 (Supplementary Concept)
Sniper(tacc3)-2 (Supplementary Concept)
zabedosertib (Supplementary Concept)
N(6),N(6)-dimethyladenine (Supplementary Concept)
AZ31 compound (Supplementary Concept)
GNE-924 (Supplementary Concept)
4-ethoxy-7H-pyrrolo(2,3-d)pyrimidin-2-amine (Supplementary Concept)
(E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (Supplementary Concept)
ensartinib (Supplementary Concept)
KAN0439834 (Supplementary Concept)
2 (4'-hydroxynaphthyl) chromen-4-one (Supplementary Concept)
6,7-dimethoxy-4-anilinoquinoline (Supplementary Concept)
tryptanthrin-6-oxime (Supplementary Concept)
CAM187 (Supplementary Concept)
INCB 54828-101 (Supplementary Concept)
GADD45beta-I (Supplementary Concept)
Nemiralisib (Supplementary Concept)
CL27c (Supplementary Concept)
KX2-361 (Supplementary Concept)
IkK-16 compound (Supplementary Concept)
AZD-0424 (Supplementary Concept)
PF-06700841 (Supplementary Concept)
acumapimod (Supplementary Concept)
senexin A (Supplementary Concept)
conteltinib (Supplementary Concept)
peposertib (Supplementary Concept)
JNK-IN-8 (Supplementary Concept)
BKI1 protein, Arabidopsis (Supplementary Concept)
Pkig protein, mouse (Supplementary Concept)
dorsomorphin (Supplementary Concept)
protein kinase inhibitor peptide (5-24) (Supplementary Concept)
PF-670462 (Supplementary Concept)
Pkia protein, mouse (Supplementary Concept)
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide (Supplementary Concept)
gedatolisib (Supplementary Concept)
Pkia protein, rat (Supplementary Concept)
2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide (Supplementary Concept)
palbociclib (Supplementary Concept)
cediranib (Supplementary Concept)
Semaxinib (Supplementary Concept)
CL 387785 (Supplementary Concept)
vorolanib (Supplementary Concept)
PFE-360 (Supplementary Concept)
3,4-diaminonaphthalene-2,7-disulfonic acid (Supplementary Concept)
NTRC 0066-0 (Supplementary Concept)
rebastinib (Supplementary Concept)
naquotinib (Supplementary Concept)
PF-04802367 (Supplementary Concept)
(S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (Supplementary Concept)
GDC-0575 (Supplementary Concept)
A131 compound (Supplementary Concept)
acrizanib (Supplementary Concept)
4-(2,3-dihydro-1H-benzo(d)pyrrolo(1,2-a)imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine (Supplementary Concept)
JH-VIII-157-02 (Supplementary Concept)
UM-164 (Supplementary Concept)
AZD7624 (Supplementary Concept)
deucravacitinib (Supplementary Concept)
upadacitinib (Supplementary Concept)
tofacitinib (Supplementary Concept)
temsirolimus (Supplementary Concept)
osimertinib (Supplementary Concept)
acalabrutinib (Supplementary Concept)
gilteritinib (Supplementary Concept)
1-(3-(2H-1,2,3-triazol-2-yl)phenyl)-N-6-(2-aminocyclohexyl)-1H-pyrazolo(3,4-b)pyrazine-3,6-diamine (Supplementary Concept)
asciminib (Supplementary Concept)
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine (Supplementary Concept)
(6,7-dimethoxy-2,4-dihydroindeno(1,2-c)pyrazol-3-yl)(3-fluorophenyl)amine (Supplementary Concept)
dacomitinib (Supplementary Concept)
bosutinib (Supplementary Concept)
ibrutinib (Supplementary Concept)
flumatinib (Supplementary Concept)
EGFR tyrosine kinase inhibitor 324674 (Supplementary Concept)
G6 stilbenoid tyrosine kinase inhibitor (Supplementary Concept)
(4-(4-(6-amino-5-(benzo(d)oxazol-2-yl)pyridin-3-yl)-1H-pyrazol-1-yl)piperidin-1-yl)ethanone (Supplementary Concept)
alectinib (Supplementary Concept)
mobocertinib (Supplementary Concept)
pirtobrutinib (Supplementary Concept)
zanubrutinib (Supplementary Concept)
abivertinib (Supplementary Concept)
quizartinib (Supplementary Concept)
ponatinib (Supplementary Concept)
neratinib (Supplementary Concept)
nilotinib (Supplementary Concept)
ceritinib (Supplementary Concept)
halofuginone (Supplementary Concept)
S-2-aminoethyl cysteine (Supplementary Concept)
clindamycin palmitate (Supplementary Concept)
bouvardin (Supplementary Concept)
sordarin (Supplementary Concept)
MITF protein, Aspergillus restrictus (Supplementary Concept)
bindarit (Supplementary Concept)
GEL protein, Gelonium multiflorum (Supplementary Concept)
cactinomycin (Supplementary Concept)
2',5'-oligoadenylate (Supplementary Concept)
pokeweed antiviral protein (Supplementary Concept)
quinupristin-dalfopristin (Supplementary Concept)
delpazolid (Supplementary Concept)
nafithromycin (Supplementary Concept)
alpha-sarcin (Supplementary Concept)
KRN 5500 (Supplementary Concept)
cryptopleurine (Supplementary Concept)
glutarimide (Supplementary Concept)
ranpirnase (Supplementary Concept)
tempol (Supplementary Concept)
5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-trione (Supplementary Concept)
1-(2-methylphenyl)-4-methylamino-6-methyl-2,3-dihydropyrrolo(3,2-c)quinoline (Supplementary Concept)
scopadulciol (Supplementary Concept)
cassigarol A (Supplementary Concept)
TY 11345 (Supplementary Concept)
3-butyryl-4-(2-methylphenylamino)-8-(2-hydroxyethoxy)quinoline (Supplementary Concept)
YJA 20379-1 (Supplementary Concept)
SPI 447 (Supplementary Concept)
timoprazole (Supplementary Concept)
2-(2-ethylaminobenzylsulfinyl)-5,6-dimethoxybenzimidazole (Supplementary Concept)
S 1924 (Supplementary Concept)
BY 831-78 (Supplementary Concept)
8-((2-benzimidazolyl)sulfinylmethyl)-1-ethyl-1,2,3,4-tetrahydroquinoline (Supplementary Concept)
3-(3-(ethoxycarbonyl)propionyl)-8-methoxy-4-((2-methylphenyl)amino)quinoline (Supplementary Concept)
ethyl 2-((1H-benzimidazol-2-yl)sulfinylmethyl)-4-dimethylamino-5-pyrimidinecarboxylate (Supplementary Concept)
T 330 (Supplementary Concept)
1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline (Supplementary Concept)
B 823-10 (Supplementary Concept)
8-(2-ethyl-6-methylbenzylamino)-3-hydroxymethyl-2-methylimidazo(1,2-a)pyridine-6-carboxamide (Supplementary Concept)
2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)imidazo(1,2-a)pyridine-6-carboxamide (Supplementary Concept)
BY 841 (Supplementary Concept)
omeprazole, sodium bicarbonate drug combination (Supplementary Concept)
YJA 20379-6 (Supplementary Concept)
3-butyryl-4-(5R-methylbenzylamino)-8-ethoxy-1,7-naphthyridine (Supplementary Concept)
YJA 20379-5 (Supplementary Concept)
SK and F 96079 (Supplementary Concept)
xanthoangelol (Supplementary Concept)
INU-101 (Supplementary Concept)
epristeride (Supplementary Concept)
N-(1',1'-dimethylethyl)-3-fluoroandrost-3,5-dien-17-carboxamide (Supplementary Concept)
L 685273 (Supplementary Concept)
turosteride (Supplementary Concept)
17 beta-benzoyl-4-aza-5 alpha-androst-1-ene-3-one (Supplementary Concept)
(22RS-N-1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide (Supplementary Concept)
4,7beta-dimethyl-4-azacholestan-3-one (Supplementary Concept)
4-methyl-4-aza-3-oxopregnane-20-carboxylate (Supplementary Concept)
SNA 4606-1 (Supplementary Concept)
Z 350 (Supplementary Concept)
17-phenylcarbamoyloxypregn-4-ene-3,20-dione (Supplementary Concept)
17-p-bromophenylcarbamoyloxypregn-4-ene-3,20-dione (Supplementary Concept)
17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one (Supplementary Concept)
8-chloro-4-methyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolin-3(2H)-one (Supplementary Concept)
N,N-diethyl-3-oxo-4-azaandrost-1-ene-17-carboxamide (Supplementary Concept)
4-(3-(3-(bis(4-isobutylphenyl)methylamino)benzoyl)-1H-indol-1-yl)butyric acid (Supplementary Concept)
17-N,N-diisopropylcarbamoyl-4-azaandrostan-3-one (Supplementary Concept)
2,3,5,6-tetrahydro-4,8-dimethylbenzo(c)quinolizin-3-one (Supplementary Concept)
8-chloro-2,3,5,6-tetrahydro-4-methylbenzo(c)quinolizin-3-one (Supplementary Concept)
4-methyl-benzo(c)quinolizin-3-one (Supplementary Concept)
3'-geranyl-2',3,4,4'-tetrahydroxychalcone (Supplementary Concept)
N-(1-(4-trifluoromethylphenyl)cyclopentenyl)-3-oxo-4-aza-5a-androst-1-ene-17beta-carboxamide (Supplementary Concept)
8-allyl-7-hydroxy-2H-benzopyran-2-one (Supplementary Concept)
alfatradiol (Supplementary Concept)
intraovarian peptides (Supplementary Concept)
plomestane (Supplementary Concept)
3,4-epoxy-5alpha-androstan-17-one (Supplementary Concept)
exemestane (Supplementary Concept)
vorozole (Supplementary Concept)
formestane (Supplementary Concept)
ozenoxacin (Supplementary Concept)
gepotidacin (Supplementary Concept)
topostin A1 (Supplementary Concept)
topostin A2 (Supplementary Concept)
topostin B (Supplementary Concept)
BE 13793C (Supplementary Concept)
TAN 1518 A (Supplementary Concept)
TAN 1518 B (Supplementary Concept)
TAN 1496 A (Supplementary Concept)
TAN 1496 C (Supplementary Concept)
TAN 1496 E (Supplementary Concept)
2,3-dihydro-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1H,12H-benzo(de)pyrano(3',4'-6,7)indolizino(1,2-b)quinoline-10,13(9H,15H)-dione (Supplementary Concept)
cauloside A (Supplementary Concept)
2,3-dimethoxy-8,9-methylenedioxy-11H-indeno(1,2-c)isoquinoline (Supplementary Concept)
leptosin C (Supplementary Concept)
leptosin F (Supplementary Concept)
norindenoisoquinoline (Supplementary Concept)
3,9-dibromo-12-(4-O-methylglucopyranosyl)-6,7.12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione (Supplementary Concept)
N,N-bis(3-(5-bromoacridine-4-carboxamido)propyl)methylamine (Supplementary Concept)
N,N-bis(3-(5-methylacridine-4-carboxamido)propyl)methylamine (Supplementary Concept)
indolocarbazole derivative R-6 (Supplementary Concept)
ethoxidine (Supplementary Concept)
dicentrinone (Supplementary Concept)
6-acyl-5,8-dimethoxy-1,4-naphthoquinone (Supplementary Concept)
2-acyl-5,8-dimethoxy-1,4-naphthoquinone (Supplementary Concept)
rosettacin (Supplementary Concept)
isocamptothecin A (Supplementary Concept)
isocamptothecin B (Supplementary Concept)
4,11-dimethoxynaphtho(2,3-f)indole-5,10-dione (Supplementary Concept)
ACH 702 (Supplementary Concept)
rubitecan (Supplementary Concept)
NU-ICRF 500 (Supplementary Concept)
exatecan (Supplementary Concept)
3-O-alpha-L-arabinopyranosyl-oleanolic acid (Supplementary Concept)
3-O-(glucopyranosyl-1-4-arabinopyranosyl)hederagenin (Supplementary Concept)
6-(3-(2-hydroxyethyl)amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno(1,2-)isoquinoline (Supplementary Concept)
topopyrone A (Supplementary Concept)
topopyrone D (Supplementary Concept)
topopyrone C (Supplementary Concept)
topopyrone B (Supplementary Concept)
1-cyclopropyl-6-hydroxy-8-methyl-4-oxo-7-(1,2,3,4-tetrahydro-2-isoquinolyl)-1,4-dihydroquinoline-3-carboxylic acid (Supplementary Concept)
demethylzeylasterone (Supplementary Concept)
4-methoxybenzo(a)phenazine-11-carboxylic acid (2-(dimethylamino)-1-methylethyl)amide (Supplementary Concept)
LMP517 (Supplementary Concept)
bis-1,3-((5,6-dihydro-5,11-diketo-11H-indeno(1,2-c)isoquinoline)-6-propylamino)propane (Supplementary Concept)
tryptophyl-tyrosyl-cysteinyl-arginyl-cysteinyl-lysine (Supplementary Concept)
lysyl-cysteinyl-cysteinyl-arginyl-cysteinyl-lysine (Supplementary Concept)
S 38809 (Supplementary Concept)
5-phenyl-2-(2'-(benzimidazol-5''-yl)benzimidazol-5'-yl)benzimidazole (Supplementary Concept)
6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one (Supplementary Concept)
CPUY013 compound (Supplementary Concept)
3-O-(N-(phenylsulfonyl)carbamoyl-17beta-N-(phenylsulfonyl)amide)betulinic acid (Supplementary Concept)
7-tert-butyldimethylsilyl-10-hydroxyhomocamptothecin (Supplementary Concept)
2,5-bis(4-hydroxy-3-methoxybenzylidene)cyclopentanone (Supplementary Concept)
kalihinol F (Supplementary Concept)
5-ethyl-9,10-difluoro-1,4,5,13-tetrahydro-5-hydroxy-3H,15H-oxepino(3',4'-6,7)indolizino(1,2-b)quinoline-3,15-dione (Supplementary Concept)
topostatin (Supplementary Concept)
belotecan (Supplementary Concept)
Cl-DACA (Supplementary Concept)
BM 2419-1 (Supplementary Concept)
BM 2419-2 (Supplementary Concept)
10,11-methylenedioxy-20-camptothecin (Supplementary Concept)
zoliflodacin (Supplementary Concept)
valrubicin (Supplementary Concept)
BE 10988 (Supplementary Concept)
4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione (Supplementary Concept)
ulifloxacin (Supplementary Concept)
prulifloxacin (Supplementary Concept)
grepafloxacin (Supplementary Concept)
azatoxin (Supplementary Concept)
PD 138312 (Supplementary Concept)
Ro 47-3359 (Supplementary Concept)
cyclothialidine (Supplementary Concept)
N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide (Supplementary Concept)
pixantrone (Supplementary Concept)
BE 22179 (Supplementary Concept)
GR 122222X (Supplementary Concept)
bis(helenalinyl)glutarate (Supplementary Concept)
bis(isoalantodiol-B)glutarate (Supplementary Concept)
8-desaminobatracylin (Supplementary Concept)
8-azabatracylin (Supplementary Concept)
sitafloxacin (Supplementary Concept)
balofloxacin (Supplementary Concept)
pazufloxacin (Supplementary Concept)
2-(4-methoxyphenyl)-5-((4-methylpiperazin-1-yl)-3H-imidazo(4,5-b)pyridin-2-yl)-3H-imidazo(4,5-b)pyridine (Supplementary Concept)
PD 161148 (Supplementary Concept)
PD 135042 (Supplementary Concept)
PD 160793 (Supplementary Concept)
CJ 12373 (Supplementary Concept)
tridemethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine (Supplementary Concept)
1,2,3-O-acetyl-1,2,3-demethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine (Supplementary Concept)
lomefloxacin (Supplementary Concept)
amifloxacin (Supplementary Concept)
asulacrine (Supplementary Concept)
3'-deamino-3'-hydroxydoxorubicin (Supplementary Concept)
VRT 125853 (Supplementary Concept)
makaluvamine I (Supplementary Concept)
makaluvamine H (Supplementary Concept)
2,3-dihydroindolizino(7,6,5-kl)acridinium chloride (Supplementary Concept)
matadine (Supplementary Concept)
4'-O-demethyl-4-(4''-(benzimidazol-2''-yl)anilino)-4-desoxypodophyllotoxin (Supplementary Concept)
GL 331 (Supplementary Concept)
UCT 1072M1 (Supplementary Concept)
UCT 1072M2 (Supplementary Concept)
7-(4-(4-tert-butylbenzyloxy)-1H-indazol-3-ylmethylsulfanyl)-4-methylcoumarin (Supplementary Concept)
4-demethoxy-3'-deamino-3'-hydroxydoxorubicin (Supplementary Concept)
4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin (Supplementary Concept)
2-(2-dimethylamino)-6-thia-2-azabenzo(def)chrysene-1,3-dione (Supplementary Concept)
WRC 213 (Supplementary Concept)
ardisin (Supplementary Concept)
1,3,4,5,6,7,8,10-octahydro-14-hydroxy-12-methoxy-11-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-9,2,5-benzoxanthiaazacyclododecine-10-one (Supplementary Concept)
1,3,4,5,6,7,8,9,10,12-decahydro-16-hydroxy-14-methoxy-13-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-11,2,5-benzoxathiaazacyclotetradecine-12-one (Supplementary Concept)
5,11-dimethyl-5H-indolo(2,3-b)quinoline (Supplementary Concept)
carbobenzoxycoumarin (Supplementary Concept)
chlorobiocic acid (Supplementary Concept)
9'-fluoro-10'-(4-methyl-1-piperazinyl)-7'-oxospiro(cyclopropane-1,3'(2'H)-(7H)pyrido(1,2,3-de)(1,4)benzoxazine)-6'-carboxylic acid (Supplementary Concept)
coumermycin (Supplementary Concept)
merbarone (Supplementary Concept)
novobiocin 401 (Supplementary Concept)
2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-(2'',6''-di-O-(3'''-(4-fluorophenylpropanoyl)))galactosyl-4H-chromen-4-one (Supplementary Concept)
finafloxacin (Supplementary Concept)
4-benzoyl-1-(4-methyl-imidazol-5-yl)carbonylthiosemicarbazide (Supplementary Concept)
rufloxacin (Supplementary Concept)
sparfloxacin (Supplementary Concept)
nadifloxacin (Supplementary Concept)
trovafloxacin (Supplementary Concept)
bastadin 14 (Supplementary Concept)
5,8-bis(2-aminoethylamino)-1-azaanthracene-9,10-dione (Supplementary Concept)
1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid (Supplementary Concept)
kibdelomycin A (Supplementary Concept)
etirinotecan pegol (Supplementary Concept)
A 62176 (Supplementary Concept)
A 85226 (Supplementary Concept)
CJ 12371 (Supplementary Concept)
CJ 12372 (Supplementary Concept)
FD 501 (Supplementary Concept)
methyl 3-(4-(bis(2-chloroethyl)amino)phenyl)-2-(2-(4-((N-isopropyl)amidino)phenyl)furan-5-carboxamido)propanoate (Supplementary Concept)
neocryptolepine (Supplementary Concept)
alpha-lapachone (Supplementary Concept)
eleutherin (Supplementary Concept)
9-bromophenazine-4-carboxamide (Supplementary Concept)
garenoxacin (Supplementary Concept)
1-(3'-hydroxypropyl)-4,6,8-trimethylfuro(2,3-h)quinolin-2(1H)-one (Supplementary Concept)
isoaurostatin (Supplementary Concept)
temafloxacin (Supplementary Concept)
flumequine (Supplementary Concept)
clinafloxacin (Supplementary Concept)
sobuzoxane (Supplementary Concept)
N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide (Supplementary Concept)
PNU-286607 (Supplementary Concept)
PF 03376056 (Supplementary Concept)
3-O-coumaroylbetulinic acid (Supplementary Concept)
2-(2'-(dimethylamino)ethyl)-1,2-dihydro-7-ethoxydibenz(de,h)isoquinoline-1,3-dione (Supplementary Concept)
3-amino-7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione (Supplementary Concept)
7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione (Supplementary Concept)
besifloxacin (Supplementary Concept)
antofloxacin (Supplementary Concept)
makaluvamine N (Supplementary Concept)
N-(2-(dimethylamino)ethyl)-5-methyl-4-acridinecarboxamide (Supplementary Concept)
alatrofloxacin (Supplementary Concept)
4-methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one (Supplementary Concept)
5-(2-(5-chloroindol-3-yl)vinyl)pyrazole (Supplementary Concept)
WCK 1734 (Supplementary Concept)
SR 107 (Supplementary Concept)
SR 103 (Supplementary Concept)
NSC 659687 (Supplementary Concept)
Ruthenium Ben (Supplementary Concept)
Ruthenium Sal (Supplementary Concept)
ellipticine (Supplementary Concept)
picric acid (Supplementary Concept)
bathophenanthroline (Supplementary Concept)
4,6-dinitro-o-cresol (Supplementary Concept)
bis(1,10-phenanthroline)copper(2+) ion (Supplementary Concept)
SF 6847 (Supplementary Concept)
Disulfiram (MeSH Term)
Pentostatin (MeSH Term)
Carbidopa (MeSH Term)
Tacrolimus (MeSH Term)
Mafenide (MeSH Term)
Dichlorphenamide (MeSH Term)
Benzolamide (MeSH Term)
Ethoxzolamide (MeSH Term)
Methazolamide (MeSH Term)
Acetazolamide (MeSH Term)
Tolcapone (MeSH Term)
Paraoxon (MeSH Term)
Parathion (MeSH Term)
Tacrine (MeSH Term)
Tetrachlorvinphos (MeSH Term)
Tetraisopropylpyrophosphamide (MeSH Term)
Rivastigmine (MeSH Term)
Isoflurophate (MeSH Term)
Malathion (MeSH Term)
Pyridostigmine Bromide (MeSH Term)
Diazinon (MeSH Term)
Dichlorvos (MeSH Term)
Naled (MeSH Term)
Neostigmine (MeSH Term)
Coumaphos (MeSH Term)
Fenitrothion (MeSH Term)
Fenthion (MeSH Term)
Galantamine (MeSH Term)
Aldicarb (MeSH Term)
Ambenonium Chloride (MeSH Term)
Propoxur (MeSH Term)
Armin (MeSH Term)
Azinphosmethyl (MeSH Term)
Carbofuran (MeSH Term)
Mevinphos (MeSH Term)
Monocrotophos (MeSH Term)
Sarin (MeSH Term)
Carbaryl (MeSH Term)
Soman (MeSH Term)
Dimethoate (MeSH Term)
Chlorpyrifos (MeSH Term)
Fonofos (MeSH Term)
Echothiophate Iodide (MeSH Term)
Edrophonium (MeSH Term)
Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester (MeSH Term)
Chlorfenvinphos (MeSH Term)
Trichlorfon (MeSH Term)
Methomyl (MeSH Term)
Methyl Parathion (MeSH Term)
Phorate (MeSH Term)
Phosphamidon (MeSH Term)
Physostigmine (MeSH Term)
Donepezil (MeSH Term)
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine (MeSH Term)
Tolmetin (MeSH Term)
Ketoprofen (MeSH Term)
Meclofenamic Acid (MeSH Term)
Mefenamic Acid (MeSH Term)
Diclofenac (MeSH Term)
Diflunisal (MeSH Term)
Naproxen (MeSH Term)
Niflumic Acid (MeSH Term)
Masoprocol (MeSH Term)
Fenoprofen (MeSH Term)
Flurbiprofen (MeSH Term)
Aspirin (MeSH Term)
Salicylates (MeSH Term)
Sodium Salicylate (MeSH Term)
Sulindac (MeSH Term)
Suprofen (MeSH Term)
Ibuprofen (MeSH Term)
Ketorolac (MeSH Term)
Ketorolac Tromethamine (MeSH Term)
Piroxicam (MeSH Term)
Indomethacin (MeSH Term)
Indoprofen (MeSH Term)
Ursolic Acid (MeSH Term)
Oxaprozin (MeSH Term)
Celecoxib (MeSH Term)
Etodolac (MeSH Term)
Meloxicam (MeSH Term)
Etoricoxib (MeSH Term)
Nabumetone (MeSH Term)
Acarbose (MeSH Term)
Abiraterone Acetate (MeSH Term)
Fluconazole (MeSH Term)
Ketoconazole (MeSH Term)
Itraconazole (MeSH Term)
Clotrimazole (MeSH Term)
Miconazole (MeSH Term)
Econazole (MeSH Term)
Voriconazole (MeSH Term)
Ofloxacin (MeSH Term)
Enoxacin (MeSH Term)
Pefloxacin (MeSH Term)
Norfloxacin (MeSH Term)
Ciprofloxacin (MeSH Term)
Mibefradil (MeSH Term)
Amiodarone (MeSH Term)
Cimetidine (MeSH Term)
Levofloxacin (MeSH Term)
Fluvoxamine (MeSH Term)
Orphenadrine (MeSH Term)
Gemfibrozil (MeSH Term)
Trimethoprim (MeSH Term)
Ticlopidine (MeSH Term)
Paroxetine (MeSH Term)
Fluoxetine (MeSH Term)
Bupropion (MeSH Term)
Cobicistat (MeSH Term)
Clarithromycin (MeSH Term)
Saquinavir (MeSH Term)
Ritonavir (MeSH Term)
Lopinavir (MeSH Term)
Pyrimethamine (MeSH Term)
Dapsone (MeSH Term)
Aminopterin (MeSH Term)
Trimetrexate (MeSH Term)
Vorinostat (MeSH Term)
Panobinostat (MeSH Term)
Rosuvastatin Calcium (MeSH Term)
Atorvastatin (MeSH Term)
Lovastatin (MeSH Term)
Simvastatin (MeSH Term)
Pravastatin (MeSH Term)
Raltegravir Potassium (MeSH Term)
Clavulanic Acid (MeSH Term)
Amoxicillin-Potassium Clavulanate Combination (MeSH Term)
Sulbactam (MeSH Term)
Piperacillin, Tazobactam Drug Combination (MeSH Term)
Tazobactam (MeSH Term)
Diethylcarbamazine (MeSH Term)
Pargyline (MeSH Term)
Tranylcypromine (MeSH Term)
Iproniazid (MeSH Term)
Isocarboxazid (MeSH Term)
Nialamide (MeSH Term)
Clorgyline (MeSH Term)
Cuprizone (MeSH Term)
Furazolidone (MeSH Term)
Selegiline (MeSH Term)
Harmaline (MeSH Term)
Harmine (MeSH Term)
Chlorphenamidine (MeSH Term)
Moclobemide (MeSH Term)
Phenelzine (MeSH Term)
Cytochalasin D (MeSH Term)
Chromomycin A3 (MeSH Term)
Dactinomycin (MeSH Term)
Zinostatin (MeSH Term)
Nitracrine (MeSH Term)
Nogalamycin (MeSH Term)
Anisomycin (MeSH Term)
Arabinofuranosylcytosine Triphosphate (MeSH Term)
Plicamycin (MeSH Term)
Rifampin (MeSH Term)
Rimantadine (MeSH Term)
Distamycins (MeSH Term)
Echinomycin (MeSH Term)
Edeine (MeSH Term)
Hydroxyphenylazouracil (MeSH Term)
Idoxuridine (MeSH Term)
Chromomycins (MeSH Term)
Mercaptopurine (MeSH Term)
Fluoroquinolones (MeSH Term)
Alpha-Amanitin (MeSH Term)
Methylazoxymethanol Acetate (MeSH Term)
Phleomycins (MeSH Term)
Mitomycin (MeSH Term)
Telbivudine (MeSH Term)
Famciclovir (MeSH Term)
Zidovudine (MeSH Term)
Dideoxynucleosides (MeSH Term)
Zalcitabine (MeSH Term)
Didanosine (MeSH Term)
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
Emtricitabine, Rilpivirine, Tenofovir Drug Combination (MeSH Term)
Emtricitabine (MeSH Term)
Rilpivirine (MeSH Term)
Tenofovir (MeSH Term)
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
Foscarnet (MeSH Term)
Stavudine (MeSH Term)
Lamivudine (MeSH Term)
Nevirapine (MeSH Term)
Delavirdine (MeSH Term)
Eflornithine (MeSH Term)
Caffeine (MeSH Term)
Papaverine (MeSH Term)
Pentoxifylline (MeSH Term)
Theophylline (MeSH Term)
Trapidil (MeSH Term)
Aminophylline (MeSH Term)
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (MeSH Term)
Dipyridamole (MeSH Term)
Dyphylline (MeSH Term)
Etazolate (MeSH Term)
1-Methyl-3-isobutylxanthine (MeSH Term)
Enoximone (MeSH Term)
Milrinone (MeSH Term)
Amrinone (MeSH Term)
Cilostazol (MeSH Term)
Simendan (MeSH Term)
Rolipram (MeSH Term)
Tadalafil (MeSH Term)
Sildenafil Citrate (MeSH Term)
Vardenafil Dihydrochloride (MeSH Term)
Thiorphan (MeSH Term)
Cilastatin (MeSH Term)
Pepstatins (MeSH Term)
Simeprevir (MeSH Term)
Leupeptins (MeSH Term)
Antipain (MeSH Term)
Proteinase Inhibitory Proteins, Secretory (MeSH Term)
Elafin (MeSH Term)
Cilastatin, Imipenem Drug Combination (MeSH Term)
Enalaprilat (MeSH Term)
Teprotide (MeSH Term)
Ramipril (MeSH Term)
Cilazapril (MeSH Term)
Fosinopril (MeSH Term)
Lisinopril (MeSH Term)
Captopril (MeSH Term)
Enalapril (MeSH Term)
Perindopril (MeSH Term)
Quinapril (MeSH Term)
Cystatins (MeSH Term)
Kininogens (MeSH Term)
Cystatin B (MeSH Term)
Salivary Cystatins (MeSH Term)
Baculoviral IAP Repeat-Containing 3 Protein (MeSH Term)
Inhibitor of Apoptosis Proteins (MeSH Term)
Neuronal Apoptosis-Inhibitory Protein (MeSH Term)
X-Linked Inhibitor of Apoptosis Protein (MeSH Term)
Sitagliptin Phosphate (MeSH Term)
Linagliptin (MeSH Term)
Vildagliptin (MeSH Term)
Tissue Inhibitor of Metalloproteinases (MeSH Term)
Tissue Inhibitor of Metalloproteinase-1 (MeSH Term)
Tissue Inhibitor of Metalloproteinase-2 (MeSH Term)
Tissue Inhibitor of Metalloproteinase-3 (MeSH Term)
Heparin Cofactor II (MeSH Term)
Plasminogen Inactivators (MeSH Term)
Tosyllysine Chloromethyl Ketone (MeSH Term)
Tosylphenylalanyl Chloromethyl Ketone (MeSH Term)
Aprotinin (MeSH Term)
Plasminogen Activator Inhibitor 1 (MeSH Term)
Plasminogen Activator Inhibitor 2 (MeSH Term)
Protein C Inhibitor (MeSH Term)
alpha 1-Antichymotrypsin (MeSH Term)
alpha 1-Antitrypsin (MeSH Term)
Amino Acid Chloromethyl Ketones (MeSH Term)
Angiotensinogen (MeSH Term)
alpha-2-Antiplasmin (MeSH Term)
Secretory Leukocyte Peptidase Inhibitor (MeSH Term)
Serpin E2 (MeSH Term)
Gabexate (MeSH Term)
Neuroserpin (MeSH Term)
Dabigatran (MeSH Term)
Antithrombin III (MeSH Term)
Hirudins (MeSH Term)
Antithrombin Proteins (MeSH Term)
Rivaroxaban (MeSH Term)
Fondaparinux (MeSH Term)
Cyclin-Dependent Kinase Inhibitor p27 (MeSH Term)
Ovomucin (MeSH Term)
Trypsin Inhibitor, Bowman-Birk Soybean (MeSH Term)
Trypsin Inhibitor, Kunitz Soybean (MeSH Term)
Atazanavir Sulfate (MeSH Term)
Darunavir (MeSH Term)
Indinavir (MeSH Term)
Nelfinavir (MeSH Term)
Genistein (MeSH Term)
Emodin (MeSH Term)
Phosphatidylethanolamine Binding Protein (MeSH Term)
Cyclin-Dependent Kinase Inhibitor Proteins (MeSH Term)
Cyclin-Dependent Kinase Inhibitor p21 (MeSH Term)
Cyclin-Dependent Kinase Inhibitor p57 (MeSH Term)
Cyclin-Dependent Kinase Inhibitor p15 (MeSH Term)
Cyclin-Dependent Kinase Inhibitor p18 (MeSH Term)
Cyclin-Dependent Kinase Inhibitor p19 (MeSH Term)
Sorafenib (MeSH Term)
Wortmannin (MeSH Term)
Sunitinib (MeSH Term)
Axitinib (MeSH Term)
Vemurafenib (MeSH Term)
Roscovitine (MeSH Term)
Everolimus (MeSH Term)
Imatinib Mesylate (MeSH Term)
Erlotinib Hydrochloride (MeSH Term)
Dasatinib (MeSH Term)
Gefitinib (MeSH Term)
Lapatinib (MeSH Term)
Afatinib (MeSH Term)
Crizotinib (MeSH Term)
Pactamycin (MeSH Term)
Tetracycline (MeSH Term)
Linezolid (MeSH Term)
Kanamycin (MeSH Term)
Lincomycin (MeSH Term)
Puromycin (MeSH Term)
Neomycin (MeSH Term)
Netilmicin (MeSH Term)
Olivomycins (MeSH Term)
Clindamycin (MeSH Term)
Cycloheximide (MeSH Term)
Fusidic Acid (MeSH Term)
Gentamicins (MeSH Term)
Capreomycin (MeSH Term)
Sisomicin (MeSH Term)
Sparsomycin (MeSH Term)
Streptomycin (MeSH Term)
Emetine (MeSH Term)
Erythromycin (MeSH Term)
Chloramphenicol (MeSH Term)
Chlortetracycline (MeSH Term)
Viomycin (MeSH Term)
Virginiamycin (MeSH Term)
Shiga Toxins (MeSH Term)
Oxazolidinones (MeSH Term)
Ribosome Inactivating Proteins (MeSH Term)
Lincosamides (MeSH Term)
Mupirocin (MeSH Term)
Homoharringtonine (MeSH Term)
Tigecycline (MeSH Term)
Brefeldin A (MeSH Term)
Omeprazole (MeSH Term)
Esomeprazole (MeSH Term)
Lansoprazole (MeSH Term)
Dexlansoprazole (MeSH Term)
Rabeprazole (MeSH Term)
Pantoprazole (MeSH Term)
Dutasteride (MeSH Term)
Finasteride (MeSH Term)
Azasteroids (MeSH Term)
Fadrozole (MeSH Term)
Aminoglutethimide (MeSH Term)
Letrozole (MeSH Term)
Anastrozole (MeSH Term)
Camptothecin (MeSH Term)
Topotecan (MeSH Term)
Irinotecan (MeSH Term)
Aclarubicin (MeSH Term)
Epirubicin (MeSH Term)
Idarubicin (MeSH Term)
Teniposide (MeSH Term)
Daunorubicin (MeSH Term)
Nalidixic Acid (MeSH Term)
Oxolinic Acid (MeSH Term)
Carubicin (MeSH Term)
Mitoxantrone (MeSH Term)
Doxorubicin (MeSH Term)
Etoposide (MeSH Term)
Cinoxacin (MeSH Term)
Dexrazoxane (MeSH Term)
Moxifloxacin (MeSH Term)
Fleroxacin (MeSH Term)
Gatifloxacin (MeSH Term)
Gemifloxacin (MeSH Term)
Tetraphenylborate (MeSH Term)
2,4-Dinitrophenol (MeSH Term)
Alamethicin (MeSH Term)
Aurovertins (MeSH Term)
Rotenone (MeSH Term)
Dinitrophenols (MeSH Term)
Venturicidins (MeSH Term)
Carbonyl Cyanide m-Chlorophenyl Hydrazone (MeSH Term)
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (MeSH Term)
Monensin (MeSH Term)

All MeSH Categories

Pharmacological Actions Category

Enzyme Inhibitors

MeSH

NLM Controlled Vocabulary

Send to:

Enzyme Inhibitors [Pharmacological Action]

Supplemental Content